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ABSTRACT 
A STUDY ON MYCOLOGICAL PROFILE OF ONYCHOMYCOSIS IN DIABETIC 
PATIENTS IN A  TERTIARY CARE HOSPITAL AND THEIR ANTIFUNGAL 
SUSCEPTIBILITY PATTERN 
INTRODUCTION: Onychomycosis among diabetics are very common and increases the 
risk of developing secondary bacterial infection and cellulitis if untreated. 
AIMS AND OBJECTIVES: To  identify  the  etiological  fungal  pathogens  in 
onychomycosis  among  diabetic patients.To  determine the epidemiological profile of 
pathogens  and to  study  the  antifungal  susceptibility  pattern  of  the  isolates. 
 MATERIALS AND METHODS : The study was carried out in the Institute of 
Microbiology in association with Department of Dermatology and Institute of 
Diabetology,Madras Medical College,RGGGH, Chennai during October 2013 to September 
2014.Nail scrapings were collected from all known diabetic patients above the age of 18 
years who were diagnosed with onychomycosis irrespective of their glycemic status.The 
samples were subjected to direct examination and culture.The fungal pathogens were 
identified and their antifungal susceptibility pattern was done. 
RESULTS:The culture and KOH positivity rate was 46.28% and 70.29% 
respectively.Candida species was the most common isolate (39.50%) followed by non-
dermatophytic moulds (34.58%) and dermatophytes(12%).Candida parapsilosis(75%) was 
the most common etiological agent among Candida species.Among non-dermatophytic 
moulds,Fusarium species was the most etiological agent.Candida species were common 
among females in finger nail infection. All the Candida species were sensitive to azole 
drugs.Voriconazole was found to have lower MIC range in non-dermatophytic moulds except 
Fusarium species.Terbinafine was found to have lower MIC range in case of dermatophytes. 
CONCLUSION: 
This study highligts the role of  C.parapsilosis as a emerging pathogen in diabetic patients 
and fluconazole  still remains as an effective antifungal agent among the Candida 
species.Non-dermatophytic moulds should not be merely considered as contaminants and the 
diagnosis should be confirmed by repeated sampling.   
1 
 
INTRODUCTION 
 
 Onychomycosis(OM) is a term which encompasses  chronic fungal infection of 
the nail plate . OM  can be caused by dermatophytes, yeasts or moulds.Onychomycosis 
accounts for about 20 - 40% of nail disorders and 30%  of mycotic cutaneous 
infections[7].Until the 1990s OM was not much discussed. But nowadays, OM are 
considered as a major source of interest and being studied in various epidemiological 
regions. 
 
 Prevalence of  onychomycosis  is about  0.5% to 5%  in the general 
population[28] .But the prevalence of  OM  depends on number of factors such as age, 
socio-economic condition ,   occupation,  climatic conditions and the immune status of 
the patient.   
 
         The worldwide prevalence of diabetes mellitus(DM) has  increased  in recent 
years. Individuals with DM acquire  infection with a greater frequency and severity, as 
they often  have neuropathy or arterial insufficiency[96]. Fungal infections constitute the 
most common type of infection among diabetics.  One of the predictors for diabetic 
foot syndrome is OM[9] . Diabetic patients are atleast twice as likely to suffer from 
onychomycosis than normal individuals. In diabetic individuals,  the prevalence of OM  
is about 22%[12]. 
 
          Diabetic individuals  with onychomycosis are more prone for gangrene and  foot  
ulcer  when  compared  to  those  DM individuals  without onychomycosis.The risk of 
lower leg amputation may be increased  if fissures or traumatic ulcerations are followed 
by secondary infections. Thus nail infections represent a risk factor in diabetic patients 
because of possible sequels[9]. 
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          The clinical presentation may vary from nail discolouration, onycholysis of nail 
plate, hyperkeratosis to destruction of nail plate. As nail plate  will be destroyed in 
many other nail disorders, it is necessary to diagnose  OM correctly.   
 
          Onychomycosis, is caused by three  groups of fungi, namely dermatophytes, 
yeasts and non-dermatophytic moulds, with the majority of onychomycosis caused by 
dermatophytes[96].   
 
 The non-dermatophytic moulds are saprophytic fungi, which can cause 
opportunistic infections in immunocompromised patients. However, their isolation 
from nails is becoming more frequent though they were intially considered as 
contaminants. But  nowdays, these  non-dermatophytic moulds are considered to be  
emerging pathogens. 
 
 Though the treatment of OM in diabetic patients is  same as that of the patients 
without diabetes, treatment is more difficult in diabetic individuals   because it  requires 
long term therapy.  Elderly diabetic patients require  a longer duration  to treat because 
the  nails may grow  slower[89] . Onychomycosis in diabetics  may be associated with  
complications like  cellulitis, diabetic foot ulcers  and gangrene  ,which will  increase 
the  admission rates in hospital and surgical interventions. 
 
 Hence early diagnosis and appropriate medical management of OM among  
diabetics using oral antifungals will  be more cost effective than treating the 
complications[89]. 
 
 The  choice  of  antifungal agent is  different  in dermatophyte,   non-
dermatophytes  and Candida infections causing OM.  Antifungal susceptibility testing 
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is important because of emerging drug resistance.Antifungal drugs  should  ideally be 
given on the basis of in vitro sensitivity of  the isolate.  
 
 Therefore, this study was undertaken to know the mycological  profile  among 
diabetic patients, their epidemiological profile and anti-fungal susceptibility patterns.                             
 
  
  
 
 
 
 
 
 
REVIEW OF 
LITERATURE 
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REVIEW OF LITERATURE 
 
 Nails are considered as one of the important component of human body, 
because the nail serves some important physiological and social functions. About 10% 
of dermatological conditions are due to nail disorders. Both  physical and social 
disability can be caused by nail disorders.So it should never be underestimated or 
disregarded.  Nail disorders  are  associated  with  number of  heritable and non-
heritetable syndrome. Nail unit may show specific changes which serves as a marker 
for wide range of systemic disorders. So nail has to be examined to complete the 
physical examination.[1] 
 
ANATOMY OF NAIL:  
 The nail unit is composed of nail matrix and nail bed epithelium(generative 
portion), nail plate (product), nail folds and grooves (its framing), cuticles, eponychium 
and hyponychium( its sheathing), and fibrocollagen (supportive tissues). The finger nail 
grows at a rate of  0.1mm per day in young adults.Toe nails grows at a slower rate 
when compared to finger nails.The nail growth is even slower in patients with 
peripheral vascular disease[92]. 
 
FUNCTIONS OF NAIL:[1]  
 Protection – Protects the terminal phalanx and finger tips 
 Auguments the sensation of touch 
 Permits scratching 
 Manual dexterity  - Gives precision in picking up small objects  
 Utmost cosmetic importance. 
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HISTORICAL ASPECTS:[2] 
 In 1829, Parisian empiric Mahon was the first to describe the mycotic infection 
of nail.  George Meissner was the first to observe the hyphal elements in Potassium 
hydroxide mount preparation from the nail sample in 1853 from an 80 year old male 
patient. The term ONYCHOMYCOSIS was first coined by Virchow in 1856.         
 
 The  potassium suchole was the first antifungal agent  used in 1903, followed by 
Whitfield’s ointment. In 1904, Dubendorfer was the first to report Candida albicans 
infection in nail sample. 
 
 In 1910[3] , A book  “Les  Teignes” was published by Raymond Sabouraud 
which includes the classification of  Dermatophytes into 3 genera,Trichophyton, 
Microsporum and Epidermophyton  along  with  the genus Acharion. 
 
 The term “Leukonychia Trichophytica” was coined by Jessner for   Superficial 
Onychomycosis in 1922. In 1926,the term “Leuconychia Mycotia” was coined by Rost 
for Superficial Onychomycosis. 
 
 In  1933,GaLitles and Evan described  the  nail  infection  due to  Hendersonula 
toruloidea.  Berseton and Keil was the first to prove that Aspergillus species can lead to 
OM in 1941.In 1948,Moore and Weises in USA reported the  additional cases of  OM 
due to Aspergillus. 
 
 Zaias in 1972[4], Classified the fungal nail infection into Distal and lateral 
subungual onychomycosis, Superficial onychomycosis and Proximal Subungual 
onychomycosis. 
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 In 2011[5] ,a new classification was proposed by  Baran  along with Distal and 
lateral  subungual onychomycosis, Superficial onychomycosis, Proximal subungual 
onychomycosis,this classification also includes Endonyx onychomycosis ,Total 
Dystrophic onychomycosis ,Mixed onychomycosis   and secondary onychomycosis . 
 
DEFINITIONS[6] 
ONYCHOMYCOSIS : 
 A term  which  encompass  the  fungal  infection of  nail, caused by 
dermatophytes, non dermatophytic moulds, or yeasts. 
 
 Onychomycosis   -  Derived from the Greek word   
 “Onyx”   -   a nail     
 “mykes”  - a fungus.  
 
TINEA UNGUIUM :  
 Fungal infection of nail by dermatophytes. 
 
UNGUAL  ONYXIS  : 
 A term which denotes the fungal  infection of nail by yeast-like fungi . 
 
UNGUAL CANDIDIASIS : 
 Denotes the fungal  infection of  nail  by  the genus Candida.  
 
UNGUAL MYCOSIS : 
 A term used to denote the fungal infection of nail if the etiological agent is an 
opportunistic filamentous fungi. 
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EPIDEMIOLOGY 
 Onychomycosis(OM)  is the most  common infection. Onychomycosis accounts 
for  about  20-40% of nail disorders and 30%  of mycotic cutaneous infections. [7]  
 
DIABETES MELLITUS 
 The worldwide prevalence of diabetes mellitus(DM) has been increased. 
Individuals with DM will acquire the infection with greater frequency and severity.  In 
DM patients increased frequency of infection is due to incompletely defined 
abnormalities in cell mediated immunity and phagocytic function associated with 
hyperglycemia and also due to diminished vascularisation.[8] 
 
 DM patients have a chance of 2.5 to 2.8 times more to acquire onychomycosis 
than the individuals without DM.  OM can result in development of foot ulcers because 
of the sharp, thick,brittle nail piercing the skin and also due to the vascular 
compromise.Vascular compromise is due to the increased subungal pressure because of 
the enlarged dystrophic nails.One of the serious complication of DM is diabetic foot 
ulcer. Foot ulcers can often lead to foot amputations  and requires hospitalisation 
among them.  One of the  significant predictor  for  foot ulcer  is OM.  In OM, as a 
result of injury  many pathogens  will enter,which will lead to the  further 
complications like osteomyelitis,cellulitis, gangrene and lower limb amputation[9]. 
Majority of the lower limb amputations are among DM patients[89]. 
 
 The  patients with diabetes and OM  have a significantly higher rate of foot 
ulceration, gangrene than those diabetic patients without OM[10].        
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NAIL CHANGES ASSOCIATED WITH   DIABETES MELLITUS[1]          
INFECTION VASCULAR LESIONS NEUROPATHY MISCELLANEOUS 
 
Paronychia       
(Acute  and 
Chronic ) 
Onychomycosis 
Onycholysis 
 
 
Beau’s line 
Onychauxis 
Pterygium unguis 
Pterygium  
inversum unguis 
 
 
Onychauxis 
Onychocryptosis 
Neurological 
dystrophy 
Reflex sympathetic 
dystrophy 
 
 
Rosenau’s                    
depression 
 
Onychogryphosis 
Pincernail deformity 
Onychomadesis 
Leukonychia 
 
PREVALENCE OF ONYCHOMYCOSIS AMONG DIABETICS              
 The prevalence  of  OM depends on many factors  such as age, socioeconomic 
conditions, occupation, immune status of the individual, climate,  environment and 
frequency of travel[11]. 
 
        AUTHOR PREVALENCE 
Saunte DM et al..,[12]
Levy LA et al..,[13] 
Dogra S et al..,[14] 
Gupta AK et al[15] 
Aditya K.Gupta et al..,[16] 
22% 
22% 
22% 
22% 
6.5% 
     
 There is a positive correlation between OM and age and the severity of nail 
changes, but there was no correlation between OM and gender, type of DM[12]. 
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 The relationship between the duration of diabetes and the prevalence of 
onychomycosis is controversial[94][16] . 
 
 The mean age of the patients with OM was same as that of the patients with and 
without DM. The prevalance  of  OM was higher among the DM patients who  had  a  
weaker control of disease[95].  
 
 In 2003 in the United States,the total annual cost for toe,foot and leg 
amputations  was almost $2 billion.These costs covered 112,551 of total amputations, 
an average cost for each procedure  is  $16,826.The total cost of amputations in 2001 
among diabetic patients was more than  $1.6 billion[89]. 
 
RISK FACTORS OF ONYCHOMYCOSIS: 
AGE AND GENDER: 
 The prevalence of  OM  in children is very low (approximately 0·4%) . This   
may be due to reduced exposure to infected environment  (communal showers, public 
changing rooms and saprophytic fungi), smaller nail surface area, faster nail growth and 
lower prevalence of tinea pedis and nail injuries [17].The disease  is more common 
among elderly.   Approximately, 10% of general population,20% of people above the 
age of 60 years,50% of people above the age 70 years and one third of DM individuals 
will have OM.[17]  
 
 OM  is more common among males when compared to females.The gender 
difference may be due to the  hormonal level differences (progesterone and other 
related hormones).[17] 
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GENETICS 
 OM is more common among certain family members suggesting the possibility 
of  intrafamilial transmission[20] 
 
 An autosomal dominant pattern of inheritance in  Trichophyton rubrum 
infection was reported.[20]  
 
 A case-control study was conducted in Mexican Mestizos  to know the 
association of HLA class II with OM. In that study the patient with culture positive for 
T.rubrum infection along with controls are taken. OM was investigated for the first 
degree relatives of the patient. By polymerase chain reaction HLA typing was done in  
case and control samples.This study suggests that HLA-DR6  confers resistance against 
T.rubrum infection.[21]  
 
 The  prevalence of tinea unguium  was higher among the childrens  with Down 
syndrome.[6] 
 
SMOKING :[22] 
 There is a strong association between  the OM and smoking history.  
 
ENVIRONMENTAL FACTORS :[17] 
 Higher prevalence of OM  was observed in the individuals who reside in urban 
areas.This  may be due to  ‘urbanization’ which is associated with  many predisposing 
factors , such as overcrowding, communal bathing areas, and clothing habits, 
geographical and climatic differences between communities. Tinea pedis is more 
common individuals who wears  shoe. A moist warm environment  is produced within 
shoe which is ideal for fungal growth.[53]  
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SPORTS [17] 
 The  prevalence of  OM  was reported to be two fold higher among atheletes 
when compared to non-atheletes. 
 
 FREQUENT NAIL TRAUMA :[6] 
 In females, trauma to the nail plate is usually due to continued exposure to 
detergents and water. Agricultural workers,  cleaning employees, construction  or iron 
and steel workers are more prone to micro traumas. Nail-biting or finger sucking, are 
common among childrens which may lead to nail trauma.   
 
IMMUNODEFICIENCY : 
 HIV infected individuals are at greater risk of acquiring T.unguium and it 
correlates with CD4 count. PSO  is more among them.The frequency of infection also 
more among the patients with lower CD counts(450cells /μL).[24] 
 
HAEMODIALYSIS PATIENTS[25] 
 A Brazilian study  reported the prevalence of OM as 39%. The most common 
isolate was dermatophye(69.23%) followed by Candida species(15.38%) and non-
dermatophytic moulds(15.38%).In  DM patient the risk of OM increses by 88% when 
compared to non- diabetic individuals on hemodialysis.This study concludes the higher 
frequency of OM among diabetics. 
 
PSORIASIS: 
 The prevalence of OM depends on the duration and type of psoriasis.The 
probability of acquiring non-dermatophytic moulds is higher among psoriatics. The 
prevalence of OM was found to be high  among psoriatic patients[26] [27]. 
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PERIPHERAL VASCULAR DISEASE: 
 The prevalence of onychomycosis  among the individuals with peripheral 
vascular disease was found  to be 36%. T. rubrum was the most common pathogen. 
Increased prevalence of OM among individuals with  peripheral vascular disease may 
be partly due to elderly and diabetic patients.  
 
CONCOMITANT DERMATOPHYTE INFECTIONS[36] 
 Jacek C.Szepietowski et al conducted a study to know the prevalence  of 
concomitant dermatomycoses in patients with OM .42.8%  have concomitant fungal 
skin infections.The most common among them is T.pedis(33.8%) . Other concomitant 
dermatomycoses were  T. cruris(4.2%) , T. corporis  (2.1%), T.manuum (1.6%), and 
T.capitis (0.5%).There presence also depends on duration of OM. 
 
CONSEQUENCES OF ONYCHOMYCOSIS :[37]  
 OM will impair the  patient quality of life and it is more than a cosmetic 
inconvenience. 
 
Physiological consequences : 
1. Exacerbates the diabetic foot and can precipitate recurrent thrombophlebitis and 
cellulitis. 
2. May trigger  the bacterial infections, pain, dermatophytic reactions. 
 
Psycho-social consequence:  Loss of self esteem, loss of confidence, anxiety and 
depression. 
 
Social effects:  Impaired relationships,Produces fear of contagion. 
 
It can also lead to economical burden. 
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CLASSIFICATION OF ONYCHOMYCOSIS: 
 Initially Zaias  classified the OM  into 3 distinct forms:  distal and lateral 
subungual onychomycosis (DLSO), superficial white onychomycosis and proximal 
subungual onychomycosis (PSO).  
 
A newer classification of OM was proposed by Baran et al.., as follows 
1)DLSO    2) SWO 3) PSO 4)EO 5)TDO 6)MO 7)SO 8) CO 
 
1) DISTAL AND LATERAL SUBUNGUAL ONYCHOMYCOSIS[DLSO] 
 This type of OM is the most common form (90%) and the most common agent 
is T.rubrum. It present as a patch of discolouration,yellow or white near the free edge of 
nail plate(lateral fold). Occasionally it may become black or dark brown. Nail plate will 
be lifted and cracks may appear because of the accumulation of soft subungual 
hyperkeratosis. Usually this type of OM starts in a single nail but soon other nails will 
be invaded and it may lead to TDO[18] 
 
2)SUPERFICIAL WHITE ONYCHOMYCOSIS[SWO] 
 This type of OM is the less common form.It involves the dorsal surface of the 
nail and present as  a well-defined powdery white patches and often away from the free 
edge. It usually involves the toe nails  and  present with a range of dyschromias 
depending on the organism involved; hence  the term “superficial white 
onychomycosis” is restrictive. 
 
 Superficial black onychomycosis caused  by Trichophyton rubrum[39] and 
Scytalidium dimidiatum[40] have been described. In HIV patients both toe and finger 
nails are affected and may co-exist with PSO[19]. The most common etiologic agent  is 
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T.mentagrophytes. Several NDM  such as Aspergillus and Fusarium species have also 
been implicated.[40] 
 
3)PROXIMAL  SUBUNGUAL ONYCHOMYCOSIS[PSO] 
 This is the uncommon form which involves the posterior nail fold. This form is 
particularly associated with AIDS patient[19]. 
 
4)ENDONYX ONYCHOMYCOSIS[EO]  
 In this type of OM invasion begins from the top surface and it penetrates deep 
into the nail plate. It is seen with endothrix scalp infection caused by T.soudanense. 
 
5)TOTAL DYSTROPHIC ONYCHOMYCOSIS[TDO] 
 This is the final common  presentation  of severe  infection of all type of OM. 
The nail plate will be completely destroyed.  
 
6)MIXED ONYCHOMYCOSIS[MO][38] 
 In the same nail different pattern of nail plate infection will be present. The 
most common form among them are PSO and SWO,DLSO and SWO.         The 
etiological agents are T.mentagarophytes, T.rubrum, Acremonium spp.,Aspergillus spp., 
and Fusarium spp.,. 
 
7)SECONDARY ONYCHOMYCOSIS[SO]: 
 The fungal agent will invade nail plate following other seconday pathological 
conditions like psoriasis.  
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8) CANDIDAL ONYCHOMYCOSIS[CO][34]   
This type of OM may present in  one of the  following four ways. 
a) Chronic paronychia with secondary nail dystrophy 
b) Distal nail infection 
c) Chronic mucocutaneous candidiasis 
d) Secondary candidiasis 
 
ORGANISMS MOST COMMONLY ASSOCIATED WITH 
DIFFERENT TYPES  OF ONCYHOMYCOSIS : [5] 
TYPE ORGANISMS 
DLSO 
 
Dermatophytes 
(T.rubrum,T.mentagrophytes,E. floccosum) 
Fusarium spp., 
Scopulariopsis brevicaulis 
Scytalidium spp., 
C.albicans 
SO 
(White or black) 
 
T.mentagrophytes, T. rubrum 
Fusarium spp., Acremonium spp., 
Scytalidium spp., 
EO T.soudanense 
T.violaceum 
PSO 
 
T.rubrum, Fusarium spp., 
 
Mixed pattern 
DLSO plus SWO 
SWO plus DLSO 
SO plus PSO 
DLSO plus PSO 
 
T. rubrum 
T. rubrum, Fusarium spp., 
T. rubrum, Fusarium spp., 
T.rubrum 
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TYPE ORGANISMS 
TDO Dermatophytes 
Scytalidium spp., 
C. albicans 
Paronychia 
With onychomycosis 
(usually DLSO or PSO) 
 
Without onychomycosis 
Candida species 
Fusarium spp., 
Scytalidium spp., 
 
Candida species 
Fusarium spp., 
 
SEVERITY OF ONYCHOMYCOSIS[98]: 
 Based on the number of nails involved and extent of nail involvement OM can 
be garaded as mild,moderate and severe .In the mild degree, ≤25% involvement   or ≤ 4 
nails involved.In moderate  degree 26 to 74% nail involvement or 5 to 8 nails involved 
and in severe  form  ≥ 75% nail involvement  or   ≥ 9 nails involved. 
 
PATHOGENESIS:[28],[18] 
DERMATOPHYTES 
STAGE OF ADHERENCE     
 Dermatophytes produce certain keratinolytic substance.The proteinases 
produced by the fungal agent will hydrolyse the keratin and  helps in the adherence and 
peneteration of arthroconidia. Also depends upon the chemical and mechanical factors. 
 
STAGE OF PENETERATION:      
 The keratinase activity of dermatophytes  can be induced by a low molecular 
weight protein peptides which  are released  from the epidermis by the action of  other  
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fungal  proteinases. So the fungal proteinase produced by other fungal agents may have 
a role. 
 
HOST RESISTANCE AND IMMUNOLOGY  
 Dermatophytes are keratinophilic organisms. They quickly digest keratin.  
 
 The  nail  provides  easy portal of  entry to  many pathogens , through the 
proximal nail fold and the distal nail fold. Although, nails are   protected by the cuticle 
and the distal sole horn, respectively . 
 
 Nail is considered to be one of the relative immune privilege site due to a very 
low level of expression of MHC (Major histocompatibility) Class I  antigens, local 
production of potent immunosuppressive agents, dysfunction of antigen presenting 
cells (APC) and inhibition of Natural Killer (NK) cell activity.  
 
VARIOUS PROTECTIVE MECHANISMS  
 Nail units have a strong innate immunity.  
 
 Dorschner et al  has shown the  increased expression of  local antimicrobial 
peptide (human cathelicidin LL-37) [29]. Normally cathelicidin LL-37 is not expressed 
in human skin, it will be induced  on exposure to infection or inflammation.Although, it 
is strongly expressed in nail unit. It has a potent activity against Pseudomonas 
aeruginosa[30] and Candida albicans[29] because of its antimicrobial activity.  A 
different pattern of  distribution of immune cells was observed in different parts of the 
nail apparatus. In the proximal nail fold (PNF) the  density of CD4+ cells  is very high 
and very low density in the proximal nail matrix (PNM).[31]Around PNF, nail bed, and 
PNM  the CD8+ T cells are rarely seen . The distribution of Langerhans cells are higher 
in epithelium of the nail bed and PNF when compared to that of the nail matrix. [33] 
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Thus due to a lack of effective cell-mediated immunity, the nail apparatus is susceptible 
to invasion by fungal organisms, if it gets exposed due to various predisposing factors. 
Hence, OM is actually a chronic infection without any inflammation. 
 
 Ventral and middle layers of the nail plate are invaded by the most 
dermatophyte species.  
 
 Highly irregular topography along with parallel ridges and grooves in  the 
ventral surface provides the excellent site for  the fungal hyphae to penetrate the nail 
plate[33].  The intermediate layer is less commonly involved.The dorsal nail plate is 
rarely involved . Hardest part is the dorsal nail plate. 
 
 The fungal pathogenicity  also depends on the species, Trichophyton 
mentagrophytes being a more active destroyer than Trichophyton rubrum. This active 
pathogenecity for the nail may be due to mechanical  or enzymatic process. 
 
 The  invasion of nail plate by dermatophytic species in  in vitro models have 
been illustrated by Rashid et al., with T. mentagrophytes[33]. 
 
YEAST 
 Candidal OM  were associated in the individuals with H/O  repeated minor 
trauma or  in those individuals who involve wet work. [32] 
 
MOULDS : 
 Moulds are non keratolytic fungi.So, they will depend on the unkeratinized 
intercellular cement otherwise it will take the advantage of  partial denaturation of nail 
keratin by pre-existing disease or trauma. Most  often it cause infection following 
trauma or pre-existing disease. The moulds usually colonize the outer layer of the nail. 
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Infections are more common in toe nails. Moulds will  produce  a frond like mycelium.  
The fungus will grow inbetween  the layers  of keratin with the help of  these fronds by 
digesting the intercellular substance as they   grow [45]. S. brevicaulis and most 
Aspergillus species are capable of sporing in vivo and these spores can be seen on direct 
microscopy of nails.[86]. 
 
ETIOLOGICAL AGENT OF ONYCHOMYCOSIS:        
 Dermatophytes are considered to be the primary pathogens(90% in toe nails and 
50% in finger nails) followed by  yeast. Previously, non dermatophytic mould(NDM) 
which were merely considered as contaminants ,but nowadays they are the emerging 
pathogens[41] .                                    
            ETIOLOGICAL AGENTS OF ONYCHOMYCOSIS[5],[11] 
DERMATOPHYTES NON-DERMATOPHYTE 
MOULDS 
YEAST 
T. mentagrophytes  
T.rubrum 
T. soudanense 
T.violaceum 
E. floccosum 
M. gypseum 
M. canis 
Acremonium species 
Alternaria species 
Aspergillus species 
Fusarium species 
Onycochola canadensis 
Geotrichum candidum 
Cladosporium carrionii 
Scopulariopsis brevicaulis 
Penicillium species 
Scytalidium dimidiatum 
Scytalidium hyalinum 
Zygomycetes 
C. albicans 
 C.parapsilosis  
C. tropicalis 
C.guilliermondii  
C. lusitaniae  
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DERMATOPHYTES[50,51,88][SKIN PLANT] 
 Dermatophytes are the major pathogen. They are hyaline septate moulds. The 
hyphae of  these organism will peneterate the stratum corneum of  nails by means of 
proteases.Dermatophytes are classified into 3 genera ,comprising 39 closely related 
species 
. 
 Trichophyton  species affects skin ,hair and nails.The Microsporum  species 
affects skin and hair. The Epidermophyton species affects skin and nail. 
 The telomorphic state has been described for only 23 dermatophytes.  
 
Based on the ecology and host preferences they are catagerised into 3 groups 
ANTHROPOPHILIC ZOOPHILIC GEOPHILIC 
T. concentricum 
T.gourvilii  
T. megninii  
T. mentagrophytes var interdigitale 
T.tonsurans 
T. rubrum 
T. schoenleinii  
T.soudanense 
T.violaceum 
T.yaoundei 
M.audouinii 
M.ferrugineum 
E.floccosum 
T. simii 
T.mentagrophytes 
var.mentagrophytes 
T.verrucosum 
T.equinum 
M.canis 
M.equinum 
M.persicolor 
M.nanum 
M.gallinae 
T.ajelloi 
T.terrestre 
M.gypseum 
M.praecox 
M.cookei 
M.fulvum 
E.stockdaleae 
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MODE OF TRANSMISSION 
CATEGORY MODE CLINICAL FEATURES 
ANTHROPOPHILIC Human to human Mild,noninflammatory;chronic 
ZOOPHILIC Animal to man Intense inflammation;acute 
GEOPHILIC Soil to human or animal Moderate inflammation 
  
 The most isolate among dermatophytes is T.rubrum of about 23 %-38% 
[52][53][28]. Other etiological agent most commonly involved in OM  were T. 
mentagrophytes,T.verrucosum,E.floccosum and Microsporum  species[54].   
    
YEAST:   
 They are continually evolving and the medically important  species belong to 2 
classes.Saccharomycetes  which contains Candida species and Tremellomycetes which 
contains Basidiomycetes fungi Trichosporon and Cryptococcus. Malaseezia species is  
also a basidiomycetes but  it belongs to a different subphylum ,the 
Ustilaginomycetes[78]. 
 
CANDIDA:  
 They are gram positive oval budding yeast cell. There are 200 anamorphic 
species of genus Candida and placed within ascomycetes.The commonest pathogenic 
species is Candida albicans.The telomorphic state have also been demonstrated for 
various species of Candida which includes Clavispora, Debaryomyces, Kluyveromyces, 
Pichia and Yarrowia[78]. 
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VIRULENCE FACTORS[44][96]  
1) Adhesins,helps in binding of Candida species  to the endothelial and epithelial 
cells. 
 
2) Enzymes - aspartyl proteases,serine proteases,lipases,esterases,phosphatases. 
These enzymes helps in facilitating the hyphal invasion. 
 
3) Complement receptors : Candida albicans have the ability to bind to the 
complement derived opsonins. 
4) Phenotypic switching : A single strain can switch reversibly among different 
colony phenotypes & thereby they evade the host immune system.  
5) Able to form bio-flim. 
 
CANDIDA AND ONYCHOMYCOSIS:[34], [35],[1] 
 It is more common in females.  Candida yeast infection of nail plate will 
present in one of the following four ways. 
 
A) CHRONIC PARAONYCHIA WITH SECONDARY NAIL DYSTROPHY  
 The most common form of CO.This form generally occurs in patients with wet 
occupations.Secondary to chronic immersion in water the posterior nail fold will be 
inflamed.The cuticle will get detached from the nail plate and lose its water-tight 
properties.Then the yeasts will invade subcuticular space and leads to further swelling 
of  posterior nail fold. 
 
B) DISTAL NAIL INFECTION : 
 Uncommon with yeasts.These patients will have some form of vascular 
insufficiency. 
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C) CANDIDA GRANULOMA:  
 It occurs in individiuals with CHRONIC MUCOCUTANEOUS 
CANDIDIASIS. This form occurs in less than 1% of onychomycosis. The entire 
thickness of the nail plate will be affected . In advanced cases,  pseudo-clubbing will 
occur. 
 
D) SECONDARY CANDIDIASIS:                                                               
 Follows other disease of nail,mostly psoriasis.   Candida  has been documented 
as the most common pathogen in OM around 46% [43]. C.albicans  are particularly 
associated with finger nails in females.  C.paropsilosis  is the most common pathogen 
among Candida species followed by C.albicans,C.gulliermondii, C.tropicalis& 
C.lusitaniae[42].    
 
MALASEEZIA SPECIES  IN ONYCHOMYCOSIS 
 The causative role  of  M. furfur in OM  is a  diagnostic problem because its 
keratinolytic ability has not been demonstrated[79]. Presence of Malassezia in the 
subungual debris is  very important, because in intensive care unit patients  it  serves as 
a source of systemic infections and is contagious[80][81].  
 
NON-DERMATOPHYTE ONYCHOMYCOSIS:[NDO]:    
 Moulds were  considered traditionally as uncommon secondary pathogens of 
diseased nails. However it constitutes  about 15% of total case of OM.  NDO are  
suspected when the patient has prominent periungual inflammation.The prevalence of 
non-dermatophytic moulds(NDM) varies with the geographical distribution of the 
population and also depends on the diagnostic criteria used.It is common in males and 
among immunosuppressed individuals.The most common type of presentation is DLSO 
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followed by SWO[46].The most common moulds are Scopulariopsis brevicaulis, 
Aspergillus species, Scytalidium dimidiatum,  Scytalidium hyalinum, Hendersonula 
toruloidea,  Fusarium species, Chaetomium globosum [47][85]. 
 
 Different studies globally have reported various rate of prevalence of NDM 
ranging from 2.3% - 45.8%[49]. 
 
 A 10 year study conducted in Korea revealed that  2.3% of OM was associated 
with NDM. 84.7% had toe nail onychomycosis and 15.3% had finger nail involvement . 
13.6% of them  had DM[48]. 
 
OTHER RARELY ISOLATED MOULDS[86] 
SPECIES REFERENCES 
Aspergillus sclerotiorum 
Aspergillus ustus 
Aspergillus unguis 
Curvularia lunata 
Exophila jeanselmi 
Geotrichum candidum 
Penicillium species 
Feuilharde de Chauvin and de Bievre 1985; 
Garcia- Martos et al 2001 
Wishe and English 1996 
Schonborn and Schmoranzer1970 
Barde and Singh 1983 Velez and Diaz 1985 
Boisseau –Garsaud et al 2002 
Restrepo et al 1976,Velez and Diaz 1985 
Walshe and English 1996, Velez and Diaz 1985 
 
 To increase the predictive power of diagnosis of nondermatophytic invasion of 
a nail,  according to Summerbell (35) the   nondermatophytes  isolated in nail tissue  
should be categorized as one of the following:  
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1. Contaminant species . 
2. Normal mammalian surface commensal organism. 
3. Transient saprobic colonizer . (colonizer of accessible surface molecules but 
non-invasive) 
4. Persistent secondary colonizer - colonizer of material infected by a 
dermatophyte but incapable of remaining after the dermatophyte is eliminated. 
5. Successional invader –  The species which can cause infection after gaining 
entry into a nail via the disruption caused by a primary pathogen . 
6. Primary invader  which are able to cause OM in a previously uncolonized nail. 
  
 Diagnosis of NDM  is difficult and it requires more than one laboratory analysis 
for confirmation.  
 
The criteria  of  English et al., [36] stated that 
1. If a dermatophyte is isolated  - Considered as the pathogen.  
2. To consider the mould and yeast as pathogen: 
 KOH mount should be positive(arthrospores,hyphae,yeast cells) 
 There should be at least five colonies of the same mould (out of 20 nail 
fragments plated per person)   with the  absence of dermatophytes. 
 
 However it is difficult to fulfill the criteria, and it leads to high false negative 
results. 
 
 Therefore, Shemer et al., suggested that when NDM  is isolated  in  the first 
culture, then the  patient should be re-examined and three separate nail samples should 
be taken. If NDM is confirmed in all of the  three cultures taken, then it is considered to 
be significant  and we have to treat accordingly.  
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DIFFERENTIAL DIAGNOSIS[47]: 
 It is difficult  to diagnose subungual tinae unguium because  of scarcity of fungi 
and the fungus is  located  in the lower most part of the nail. 
 
These are the following conditions which mimic Onychomycosis  
 
 CONGENITIAL CONDITIONS 
 Non mycotic leukonychia,clubbing,Beau lines,Pachyonychia congenital 
 EXTERNAL CONDITIONS 
 Onychogryposis,Onychophagy,ingrowing toe nails 
 DERMATOLOGICAL DISEASE CONDITIONS 
 Eczema,Lichen planus,Bacterial paronychia,Dariers disease, 
 Raynauds disease,Psoriasis,Nail bed tumors.                  
 
 Among these, psoriatic nail is exteremly difficult to diagnose. The systemic 
disease will affect several nails and symmetric in distribution.But in T.unguium it will 
involve only single nail and it is assymmetric in distribution. 
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LABORATORY DIAGNOSIS:  
 ALGORITHM FOR DIAGNOSIS OF ONYCHOMYCOSIS[28] 
      
 
           
                                          
 
                                                                                                                                       
      
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                  
 
        
                                                                    
 
 
 
  
   CLINICAL  SUSPICION  OF   OM 
DIRECT 
MICROSCOPY 
Sensitivity : 48-80% 
FUNGAL CULTURE 
Sensitivity : 25-80% 
POSITIVE 
FOR NDM 
POSITIVE FOR 
DERMATOPHYTES 
POSITIVE                    
FOR 
DERMATOPHYTE
POSITIVE 
FOR NDM 
TREAT 
ALONG 
WITH 
CULTURE 
REPORTS 
   
TREAT 
REPEAT   
THE 
CULTURE 
TREAT 
IF NEGATIVE LOOK FOR THE 
CLINICALLY SIMILAR 
CONDITIONS  
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SAMPLE COLLECTION 
 Collection of  appropriate sample is very important for successful laboratory 
diagnosis. Sample collection method differs with the type of OM[11]. 
 
 For all types of  OM,nails should be first cleaned with alcohol to eliminate the 
contaminants like bacteria[35]. 
 
DLSO  
 Samples should be collected from the nail bed  because the concentration of 
viable fungi is the greatest[68]. Using nail clippers the nails should be clipped short. 
Using a small curette or no.15 scalpel blade the samples should be collected from the 
nail bed as close to the cuticle[35].  
 
PSO 
 Using a sharp curette scrapings  should be taken  from the  infected nail as 
proximal as possible to lunula[55].  
 
SWO 
 Using no.15 scalpel blade, first few scrapings  from the outermost surface 
should be discarded and then the underlying debris is collected.[67] 
 
EO 
 Scrapings are taken from the discolored portions[55]. 
 
CANDIDAL OM 
 Scrapings are taken from the proximal and lateral nail fold[55]. 
 
TDO 
 Scrapings can be taken from any of the diseased part of nail plate or bed[11]. 
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 The samples collected by means of drilling technique  has been found to have 
improved culture sensitivity.Vertical drilling technique has been found to useful in 
PSO.To obtain  full thickness of the nail, nail clippers should be used[28] .  
 
 Strong black paper or  black photographic paper can be used for sample 
collection because it will gives better visualization regarding the amount of scrapings to 
be obtained[62].The paper also allows the specimen to dry out  so that it helps in 
reducing bacterial contamination[75].Then the paper can be folded tightly and the 
corners are sealed. 
 
Two commercial package systems for transport is available. 
1) Myco Trans(Bigger,UK) 
2) Derma pak(Dermaco,UK) 
 
CONVENTIONAL METHODS 
DIRECT MICROSCOPIC EXAMINATION 
 
 KOH MOUNT[62]- A simple,rapid and inexpensive method to  confirm the 
diagnosis. The sample is incubated in 10-30% KOH( potassium hydroxide) solution 
.KOH will digest keratin, so that  the fungal hyphae will be clearly visible. The nail 
specimens can take a longer time to clear. The subungual debris  can also  be examined 
within 10 minutes with 10-15% KOH. If the nail sample is larger it should be made up 
into smaller pieces and then incubated at 37ºC for one minute and then 
examined[28].40% DMSO can also added along with KOH because DMSO will 
facilitate  clearing .Alternatively NaOH with 5% glycerine can also be used[62] .The  
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sensitivity rate of KOH varies from 48% to 80%[28]. To improve the visualisation 
Parker’s Blue black ink can also be used along with KOH[11]. 
 
 Calcofluor  white stain and other special stains can also be used for direct 
examination.  Recently, Lim and Lim reported  the use of  Chicago sky blue(CSB) stain 
to improve the sensitivity as well as specificity . Under 40X magnification fungal 
elements can be easily visualized on normal bright-field microscopy.  However,species 
differentiation cannot be done by direct microscopy [28].  
 
HISTOPATHOLOGY 
 The current  Gold standard  method for the diagnosis of OM  is PAS (periodic 
acid Schiff stain)[59]. For histopathological examination,  nail clippings are taken and 
fixed with formalin for 4-8 hours and then softened [using agents like Potassium 
hydroxide (KOH), 5% trichloroacetic acid, 10% Tween- 40, or chitin softening solution 
containing mercuric chloride]. Then the softened  sample  is fixed in 10% buffered 
phosphate formalin for 24 hours, dehydrated and then embedded. Using a 
microtome,semi-thin sections (5 microns) are taken and  then stained with periodic 
acid-Schiff (PAS). This  procedure  takes for about 24-48 hours.  
 
 Sufficient amount of subungual debris is  enough to confirm the diagnosis and 
even the nail plate may not be required[60].  
 
 PAS is found to be the most sensitive  test with a sensitivity rate  of 82%. The 
sensitivity of culture is 53% and direct microscopy is 48%.[66]Histopathology is 
valuable because it gives a clue of level of invasion and arrangement.Staining with 
Grocott methenamine-silver (GMS)  was shown to be superior to PAS because  it gives 
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a better contrast between fungus and surrounding materials. But, the procedure is more 
complex[28].  
 
 HPE is useful for differentiating the dermatophytes, yeast and NDM and allows  
the  examination of mycelia threads and spore morphology in detail. However,  it is a 
time consuming procedure which needs to be overcome. 
 
CULTURE[28] 
 Isolation of the fungal pathogen from nail is more difficult.The sample taken 
from the distal end of nail  are usually  non-viable,so it will not grow in culture.  The 
hyphae in the proximal  end of the nail  are viable.The culture results  can be improved 
if samples are taken from more proximal sites. Because of discomfort, it is difficult to 
obtain proximal sample.              
 
 Previously, the culture was considered  as the gold standard  techinque of 
diagnosis, which can identify the involved fungus. The  sensitivity of  culture varies 
from 25 to 80%[56]. False negative results accounts for about 30% of cases, particularly  
when the sample is insufficient, taken from distal portions or is not crushed prior to 
inoculation[56],[57].  
 
 Specimens should be inoculated onto two different media. Sabouraud dextrose 
agar with gentamicin to isolate all the fungi  including yeasts and NDM and a 
Sabouraud dextrose agar with cycloheximide  and chloramphenicol  for isolation of 
dermatophytes .  Cylohexmide will inhibit the growth of NDM.Cultures are incubated 
for three to four weeks and examined weekly.  The isolates are identified on the basis 
of the growth pattern,macroscopic appearance and microscopic examination. If both the 
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media shows growth ,the etiological agent is dermatophyte. If the growth is seen only 
in cycloheximide free medium,then the etiological agent may be NDM[28]. 
 
DERMATOPHYTE TEST MEDIUM(DTM)[58] 
 This is an alternative culture media  originally described  by Taplin et al for 
presumptive  identification  of  dermatophytes. The growth  is indicted by the change in 
colour of the medium as a result  of  pH change.(YELLOW TO RED).The medium 
contains cyclohexamide which will inhibit the growth of saprophytic fungi  and 
gentamicin which inhibits the growth of bacteria.  The  cultures can be identified within 
one week.But it may give rise to false positive results.Dermatophyte test medium can 
be used as alternative for presumptive identification of  dermatophytes. 
 
DERMATOPHYTE IDENTIFICATION MEDIUM:[61] 
 It is also used as presumptive identification medium of dermatophytes.Here the 
medium changes from greenish blue to purple within 24 to 48 hours. The false positive 
results are less than that of DTM. 
 
OTHER SPECIAL MEDIA: 
BROMOCRESOL PURPLE MILK SOLID GLUCOSE MEDIUM[62]: 
 It is a differential medium used for identification of dermatophytes.Growth is 
indicated by colour change in the medium.Available commercially as Dermatophyte 
milk agar. Type of growth and change in pH  are useful in differentiating T.rubrum 
from T.mentagrophytes,T.mentagrophytes from M.persicolor. 
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CORN MEAL AGAR WITH 1% DEXTROSE[62] 
 This medium is used to differentiate T.mentagrophytes from T.rubrum.Here the 
dextrose will promote  the growth and pigment production  of T.rubrum. 
 
TRICHOPHYTON AGAR 1 TO 7 [62]   
Based on the growth requirements the Trichophyton species can be 
identified.They are a set of 7 media with different growth factors.Growth in all the 
seven media is scored and the species are identified.  
 
SPECIAL MEDIA FOR SPORULATION INDUCTION[62]: 
 The sporulation can be induced in nutritionally deficient medium such as Potato 
Dextrose Agar,Potato Flake Agar,Corn meal agar,Corn meal glucose agar. 
 
INVITRO HAIR PERFORATION TEST[62]: 
 This test distinguishes between the atypical isolates of T.mentagrophytes and 
T.rubrum.It is also used to distinguish M.canis and M.audouinii and also between 
M.praecox and M.gypseum. 
 
POSITIVE 
(Wedge shaped perforation seen 
perpendicular to the hair shaft) 
NEGATIVE 
(No perforation) 
T.mentagrophytes T.rubrum 
M.canis M.audouinii 
M.gypseum M.praecox 
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UREASE TEST[[62] 
 The ability of the pathogen to hydrolyse urea can be utilized to differentiate 
T.rubrum(Negative)  from T.mentagrophyes(Positive). 
 
NEWER METHODS 
POLYMERASE CHAIN REACTION[28] 
 Nowadays  various molecular techniques using PCR assay have been evaluated. 
It is  an accurate, rapid and  stable method  for identifying pathogenic fungi from  both 
the nail samples and from the fungal colonies. The methods used in samples from 
cultured colonies include Arbitrarily primed PCR, real-time PCR, PCR-restriction 
fragment length polymorphism (RFLP), PCR-direct sequencing  and double-round 
PCR are the methods  used for identifying the pathogen in cultured colonies.Specificity 
of PCR is excellent. Disadvantage of this method  is risk of contamination and it cannot 
differentiate pathogenic from non pathogenic fungi.[63] 
 
 To detect the etiological agent from the  nail sample directly Li et al., developed 
and evaluated the efficacy of triplex PCR procedure which had a sensitivity and 
specificity of  93.3%  and 100% respectively.This method will distinguish the  three  
groups of fungi in OM and could be completed within 8 hours. [63] 
 
OPTICAL COHERENCE TOMOGRAPHY  
 This method is non-invasive.It employs  non-contact cross-sectional imaging of 
biological tissue  and detects the back scattering near infrared light of the 
inhomogenities within the sample.The hyperkeratotic nail will have lower light 
scaterring area.The high signal intensity is seen with hypal element due to their chitin 
concenteration[65] . This method is superior to KOH and cultures.Hence, it is a reliable, 
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easy, noninvasive  method to visualize fungal elements in vivo.[65]  Its availability and 
cost effectiveness are not favorable for use in clinical practice. 
 
CONFOCAL LASER SCAN MICROSCOPY[28] 
 An in vivo test  used in diagnosis of OM[64]. It is unsuitable for routine use, 
because it is  expensive and complicated . Several reports shown that misdiagnosis is 
common and it is a time consuming procedure.  
 
MATRIX-ASSISTED LASER DESORPTION/ IONIZATION  
TIME-OF-FLIGHT MASS SPECTROMETRY (MALDI-TOF MS) 
 This method is based on detection of biochemical characteristics as a result of 
the activity of noninfectious diseases or due to mycological infections. This  technique 
analyses the protein patterns of nail samples. Identification is by  comparing the known  
peptide pattern from various nail disoders which is already existing in data bases with 
that of the peptide pattern in nail sample. A distinct advantage of this method  over the 
conventional method(KOH and Culture)  is its ability to differentiate between OM and 
non-fungal nail disorders   This method is fast and results are available within 
24hours.Sample preparation is also simple[28]. 
 
PHASE CONTRAST HARD X-RAY MICROSCOPY 
 This method  uses phase contrast microscopes utilizing synchrotron radiation. 
The internal structures of the sample can be imaged precisely  because of high 
resolution and brightness.This method does not require fixatives or stains[28].  
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IDENTIFICATION OF CANDIDA SPECIES 
GERM TUBE TEST[REYNOLD’S-BRAUDE PHENOMENON] 
 Germ tube test is used to differentiate between the Candida albicans and   non-
albicans species. 
 
SUGAR FERMENTATION TEST 
 This test can be used to differentiate between the Candida species based on the 
fermentative patterns. 
 
SUGAR ASSIMILATION TEST  
 This test determines the ability of  the  yeast to  utilize the  particular  carbon 
compound as sole source of energy under aerobic conditions. These tests can be 
performed on liquid or solid medium. 
 
a) LIQUID MEDIA 
 Wickerham and Burton (1948) and Wickerham (1951) described the test by 
employing liquid media.  
 
b) SOLID MEDIA  : can be done in two ways.  
1) Auxanographic method of Beijerinck (1889) By suspending  the yeast in 
agar  in  pour  plates and the individual  test sugars  are  placed at intervals 
around the circumference. 
 
2) In another method ,the test compound is  incorporated onto a nutrient agar 
basal   medium and the test isolate is inoculated as  a streak on the surface of 
the petri plates.   
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 The disadvantage of agar plate is it tends to dry within a few days ,so delayed 
growth reactions cannot be detected. 
 
But  the advantage of using petri plates are 
 The results can be read within 2 to 4 days 
 Any contaminating organisms  if present can be easily  seen  
 
 Auxanographic method  is  more reproducible  than  the Wickerham  method  
because of   its simplicity and ease in interpreting results[83]. 
 
CORN MEAL AGAR MEDIUM 
 Used to study the morphology of yeast such as blastoconidia, 
chlamydoconidia,true hyphae,pseudohyphae and arthroconidia. 
 
CHROMagar Candida medium 
 It is a differential and selective chromogenic medium to identify Candida 
species. These media are based on direct detection of specific enzymatic activities by 
adding substrates of flurochromes to media.CHROM  agar Candida medium is useful  
in rapid and presumptive identification of Candida species within 48 hours[82]. 
 
NITRATE ASSIMILATION TEST:   
 It tests the ability of the yeast to utilize nitrate as a sole source of nitrogen 
source.However,it has limited value for identification of yeast and are primarily used 
for discrimination of Cryptococcus species. 
 
RAPID TREHALOSE TEST  
 It helps in the presumptive identification of C.glabrata within 3 hours[78]. 
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COMMERCIALLY AVAILABLE YEAST IDENTIFICATION TESTS[76]. 
 API-20C AUX  system is based on  carbohydrate substrate utilizaton 
profiles.The limitation of the  system is that it cannot identify the unusual 
species. 
 
 Microscan Yeast Identification Panel 
This system uses the chromogenic substrates to asses the enzymatic activity. 
 
 VITEK Biochemical Cards-The yeast biochemical card is a 30 well, 
disposable plastic card that contains conventional biochemical tests and 
negative controls.It is used with the automated Vitek II system used for 
bacterial identification .The overall accuracy of the system in identification is 
nearly 100% when compared with API-20C AUX system.  
 
 Matrix-Assisted Laser Desorption Ionization Time-Of-Flight(MALDI-TOF) 
This method is emerging as a rapid identification technique of yeast and fungal 
isolates,will reduce the turn around time.  
 
MOLECULAR METHODS: 
PCR-RFLP METHOD[93]:  
 Rasoul et al used PCR-RFLP method in speciating 322 Candida isolates.ITS1-
ITS2 region of the extracted yeast isolate is amplified by PCR method,PCR products 
are digested by MspI restriction enzyme.Within the C. parapsilosis group, SADH gene 
was furher amplified and the products were digested by NlaIII restriction enzyme to 
discriminate C. parapsilosis, C. metapsilosis and    C. orthopsilosis.                                       
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TREATMENT OF ONYCHOMYCOSIS[89]:  
 It is very important to treat OM because it does not resolve spontaneously and if 
left untreated it can spread to other nails and serves as a reservoir of infection for other 
peoples.OM  is very difficult to treat because of long growth period of the nail,hardness 
of nail plate and the location of infection between the nail bed and nail plate. The 
therapy also depends on many factors such as  the site of involvement, severity of the 
disease, the etiological agent, number of nails, concomitant drugs and choice of drug by 
the  patient/physician[87]. 
 
 The treatment of OM in diabetics is same as that of non-diabetic individuals. 
The elderly DM individuals require longer duration of therapy because nails grow more 
slowly among them.The DM patients with onychomycosis have a higher rate of 
secondary infections and  complications .The rate of relapse is higher among the elderly 
patients above 55 years of age[89]. 
 
 The  several treatment modalities used in onychomycosis among diabetic 
patients are topical, systemic, combination therapy  and nail removal.  
 
1) TOPICAL AGENTS:        
 The three classes of topical antifungal agents available are imidazoles  
(e.g., clotrimazole), polyenes (e.g., nystatin),  and allylamines- benzylamines 
(e.g., terbinafine). All of  the three agents are effective against Candida, but only 
allylamines-benzylamines  and imidazoles are effective against dermatophytes. 
Because of inadequate penetration of the drugs  into the affected  site of tissues and nail 
bed,topical agents are not effective in clearing the nail infections.The topical agent is 
useful in SWO, because the pathogen grows on the upper surface of  the nail plate.       
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 Antifungal nail  lacquers such as  amorolfine and ciclopirox are available in 
treating OM and penetrates the nail better than the creams and gels.  
 
 Topical antifungal agents are useful in the reduction of  reinfection and  relapses 
once the initial infection have been treated completely .  
 
2) SYSTEMIC  
 The standard oral therapy for OM was griseofulvin for more than  30 years.  It 
is active against dermatophytes only,also has several drug interactions and and adverse 
effects.The cure rate is less than 40%.Because of these reasons,  it is rarely used 
nowadays.                                                                                                                      
 
 The imidazole group of antifungal agents are active against 
Candida,dermatophytes and non-dermatophytes.But they also has significant side 
effects and drug interactions. 
 
 A triazole antifungal agent ,Itraconazole has fewer side effects.It is effective 
against Candida ,dermatophytes and  some moulds. Azole antifungals, fluconazole and 
itraconazole , have been shown to elevate  the levels of oral hypoglycemic agents. 
Itraconazole has been found to be effective and safe in DM  patients at a dose of 200 
mg twice daily. No statistically significant changes in hemoglobin A1c levels have been 
noted in diabetic patients receiving pulse itraconazole for 3 months. The mycological 
cure rate of  OM is 79% after 6 months of therapy. Pulse therapy has been shown  to be 
just as effective as the continuous therapy.    
 
 Candidal OM can be treated effectively with fluconazole.  
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 Terbinafine, an allylamine antifungal agent, is the drug of choice in treating 
onychomycosis. It is highly active in in vivo against dermatophytes , however  not 
active against  Candida  and  mould species.There is no significant interactions with 
oral hypoglycemic drugs.Terbinafine is relatively safe in DM patients and it  is 
acceptable for  long-term maintenance of the  healthy nails in diabetic patients.  
 
 Terbinafine, 250 mg once daily for 3 months, has been shown to achieve a 
mycological cure rate of 71% in fingernail OM  and 82% in toenail OM.Pulse therapy 
with terbenafine has been formulated and it is not efficacious as continuous therapy. 
 
3) COMBINATION THERAPY                                                                                              
 The newly developed treatment option is combination of oral and topical 
antifungal drugs, which will increases the likelihood of cure. One study repoted that the 
efficacy of terbinafine has been improved when combined with topical amorolfine[90]. 
Another  study showed the  improved efficacy of continuous itraconazole when 
combined with topical amorolfine[91]. The  mycological cure rate of continuous 
terbinafine is  88.2%,when it is combined with topical ciclopirox mycological cure rate 
is 64.7%.   
 
4) SURGICAL   
 It is used as an adjuvant therapy,involves the removal of nail either chemically 
or surgically.  Surgical removal of  nail is rarely used in treatment of OM in DM 
patients because of their increased risk of secondary infectons,poor wound healing and 
gangrene. 
 
 Urea ointment is used in chemical avulsion .It is preferred to surgery because it 
is a painless method[87]. 
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 Depending on the age and health of patient, side effects, drug interactions, 
dosage schedule, cost of treatment and patients compliance the physician should choose 
the treatment option[87]. 
 
CLINICAL CURE: 
 The  term clinical cure means disappearance of all lesions on each nail or 
residual disease of no more than 10% of original disease surface[88]. 
 
MYCOLOGICAL CURE: 
 Negative culture and negative microscopy indicates mycological cure[88] .  
 
EDUCATION:    
 Education of the patient plays an important role in treating the infection.High-
risk diabetic patients, those with peripheral vascular disease or peripheral neuropathy, 
should be educated properly about  foot and leg examinations.  
 
ANTIFUNGAL SUSCEPTIBILITY TESTING :   
 Relapses are common in OM patients. By doing in-vitro antifungal 
susceptibility  an effective antifungal agent can be selected for treatment and thus helps 
in optimizing the theraphy[69].The resistance may  be intrinsic or acquired[84]. 
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FACTORS THAT ARE RESPONSIBLE FOR CLINICAL ANTIFUNGAL 
RESISTANCE[84] 
HOST FACTORS FUNGAL FACTORS DRUG FACTORS 
Immune status 
Severity  
of infection 
Site of infection 
Poor adherence to 
regimen 
Presence  
of foreign material 
CELL TYPE 
 Morphology 
 Serotype        
Bioflims       
Cell states 
Genomic stability of the 
strain 
Species and strain 
Size of population 
Strain MIC 
Population bottle necks 
PHARMACOKINETICS 
    Absorption 
    Distribution 
     Metabolism 
DOSING 
     Freqency 
     Quantity 
     Cumulative dose 
Fungistatic nature of drug 
Drug- drug interactions 
        
 The antifungal susceptibility testing  are  based on the standards set by The 
Clinical Laboratory Standard Institute(CLSI). 
 
 Document M38-A2 describes the standard  reference method for Antifungal 
susceptibility testing of filamentous fungi by broth dilution method. The standards for 
susceptibility tesing are very specific  in the test medium,inoculum size,incubation 
temperature and time,pH and end point determination.The medium recommended is 
RPMI 1640 (with glutamine,without bicarbonate and with phenol red as 
indicator,pH=7.0).A 7 day old culture on PDA should be used for inoculum 
preparation. DMSO should be used to dissolve water insoluble drugs.The inoculated 
microtiter plates should be incubated at 25°C for 48 hours. 
 
 M27-A3,Reference method for Antifungal susceptibility testing of yeasts by 
broth microdilution method.A 24 hour old culture should be used and turbidity should 
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be matched with 0.5Mc Farland opacity standard. The inoculated microtiter plates 
should be incubated at 37°C for  24-48 hours. 
 
 M44-A2,describes the method antifungal susceptibility testing of yeast by disk 
diffusion method[74].  
 
 A  good correlation  between the in vitro data( broth microdilution method) and 
clinical outcome has been documented[73]. 
 
 However a standard reference method for dermatophytes is not available[69].  
The  most important  aspects of  doing antifungal susceptibility test are the inoculum 
size and its  constitution, the incubation time and temperature which have an influence 
on  the susceptibility result[70][71][72]. 
 
  
  
 
 
 
 
 
 
AIMS & 
OBJECTIVES 
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AIMS & OBJECTIVES 
 
 To  identify  the  etiological  fungal  pathogens  in onychomycosis  among  
diabetic patients. 
 
 To determine the epidemiological pattern of the pathogens associated with 
onychomycosis.  
 
 To  study  the  antifungal  susceptibility  pattern  of  the  isolates.  
        
  
  
 
 
 
 
 
 
           MATERIALS &       
                   METHODS 
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MATERIALS AND METHODS 
 
PLACE OF STUDY:  
 This study was conducted at  The Institute of Microbiology in association  with   
Institute  of  Diabetology  and  Department  of  Dermatology , Madras Medical College 
&   Rajiv Gandhi Government General Hospital, Chennai . 
 
STUDY DESIGN:       
 Cross-Sectional study 
 
STUDY PERIOD 
 The study period was for one year from October 2013 to September 2014. 
 
ETHICAL CONSIDERATION 
  Approval was obtained from the institutional ethics committee before the 
commencement of the study. Informed consent was obtained from the study population. 
All patients satisfying the inclusion criteria were recruited for the study. 
 
INCLUSION CRITERIA: 
  All known diabetic patients above the age of 18 years  who were clinically 
diagnosed as onychomycosis, irrespective of their current glycemic status were 
included. 
 
EXCLUSION CRITERIA:[97] 
 Patients on topical antifungal agents for past  four months . 
 Patients on systemic antifungal agents for past  nine months. 
 
 
47 
 
DATA COLLECTION: 
             Patients’ name,age,sex ,address, occupation, duration of OM ,              immune 
status of the patient, H/o trauma, type of DM, duration of DM, blood glucose levels 
were noted. 
 
CLINICAL EXAMINATION: 
The patient was examined for the following: 
 
 Type of OM, colour of the nails, number of nails involved, toe/finger nails, 
associated conditions like psoriasis, concomitant dermatophytic fungal infections 
affecting skin/hair. 
 
STUDY POPULATION 
Sample size: 175  
SAMPLE COLLECTION, TRANSPORT AND PROCESSING: 
SAMPLE:  
 The nail scrapings and subungual debris were collected from all patients.   
 
COLLECTION : 
 The surface of the nail was first disinfected with 70% alcohol to remove the 
bacterial contaminants.Then the nail samples were obtained according to the type of 
onychomycosis. A no.15 sterile scalpel blade was used to collect the samples.  
 
DISTAL LATERAL SUBUNGUAL ONYCHOMYCOSIS 
 The nails were clipped short  using nail clippers. The  scrapings were obtained 
from the nail bed proximally to the site of infection. 
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SUPERFICIAL WHITE ONYCHOMYCOSIS 
 The first few scrapings were discarded and the underneath debris were 
collected. 
 
PROXIMAL SUBUNGUAL ONYCHOMYCOSIS 
 The scrapings were obtained as proximal as possible to lunula of the infected 
nail.  
 
CANDIDAL ONYCHOMYCOSIS 
 The scrapings were obtained from lateral and proximal nail fold. 
 
ENDONYX ONYCHOMYCOSIS 
 The scrapings were taken from the discolored portions. 
 
TOTAL DYSTROPHIC ONYCHOMYCOSIS  
 The scrapings were obtained from the proximal diseased part of the nail. 
 
 The scrapings  were  collected  on  a  sterile  glass  slide and subjected to  
KOH examination and culture  immediately. 
 
PROCESSING  
KOH MOUNT 
 20% KOH and 40% KOH were used for finger nails and toe nails respectively. 
The scrapings were placed on a sterile glass slide,a drop of  KOH  added and a 
coverslip  placed over it. Then the slide was gently passed over the flame and examined 
under 10X and 40X objective of the light microscope. Then the slide was examined for 
the presence of  hyphae, arthrospores, pseudohyphae  and budding yeast cells. 
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TUBE KOH  
 Tube test  for  tube  KOH was used for those nail samples which took longer 
time to dissolve. The nail sample was dissolved in 10% KOH and incubated at 37ºC 
overnight and examined under the light microscope next day. 
 
CULTURE 
The samples were inoculated immediately  onto the following  culture media. 
 
1. Two tubes of Sabouraud Dextrose Agar  with cyclohexamide(500mg/L) and 
chloramphenicol(50mg/L) were incubated at 22ºC and  37ºC for 4 weeks. 
2. Two tubes of Sabouraud Dextrose Agar   without cyclohexamide and 
chloramphenicol and with gentamicin(20mg/L) were incubated at 22ºC and 
37ºC for 4 weeks. 
3. Dermatophyte test medium was incubated at 22ºC for 2 weeks.   
 
The non dermatophytic moulds and yeasts were considered as pathogen based on 
English and Walsh criteria[36]: 
 A positive KOH mount  
 More than 5 colonies in the medium and 
 If the isolate yielded was the same in all three succesive cultures.  
 
 If the conidiation was poorly formed in SDA, the media was  enriched with  
thiamine. 
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MACROSCOPIC EXAMINATION OF CULTURE TUBES 
 The culture tubes  were  examined  regularly  for  fungal  growth for upto 4 
weeks  in  SDA  and  in  DTM for 2 weeks.The duration of growth, colour and texture  
of  the  growth  were  noted  and  then subjected to microscopic examination. 
 
MICROSCOPIC EXAMINATION 
LPCB MOUNT  
 A drop of LPCB was placed a clean glass slide. A small portion of the colony 
was taken using a spade and placed on the mounting fluid. The mycelial fragments 
were teased  apart  with the help of two teasing needles. A coverslip was placed over it 
and  examined under 10x and 40x objective of the light microscope. The type of 
hyphae,conidia and their attachment with condiophore/sporangiophore are examined 
and identified .Slide culture was performed for those isolates which could not be 
identified by LPCB mount. 
 
SLIDE CULTURE: 
 The nutritionally deficient medium, PDA was used for the slide culture. A 1cm 
square agar block was cut out  from PDA using a sterile scalpel. The agar block was 
transferred carefully with sterile precautions onto the sterile glass slide placed in a 
sterile petridish.  A very small amount of the colony was inoculated onto the four sides 
of the agar block. One ml of sterile distilled water was added to a sterile container 
placed in the petri dish. The inoculated medium was incubated at room temperature and 
observed for growth. When good growth was observed, two permanent mounts were 
prepared. The coverslip was removed  from the agar block with the  help of sterile 
forceps and observed microscopically after adding LPCB. The agar block was also 
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removed and a drop of LPCB placed over the slide ,coverslip was placed and  observed  
under 10x and 40x objective of the light microscope. 
  
IDENTIFICATION OF DERMATOPHYTES: 
 Dermatophytes were identified and speciated based on macroscopic and 
microscopic features of culture. The other additional tests used to differentiate the 
various dermatophytes were as follows. 
1) UREASE TEST:   
 Christensen’s urea agar slope was inoculated  and incubated at 25ºC for upto 
7days.The hydrolysis of urea was indicated by a colour change to pink.This test was 
done to differentiate Trichophyton mentagrophytes and Trichophyton rubrum. 
 
2) IN-VITRO HAIR PERFORATION TEST:  
 A  piece  of  sterile  filter  paper  was  placed  in  a  sterile  petridish  containing  
2ml of 10% diluted sterile yeast extract. Ten  strands of sterile prepubertal hair of 
approximately 1cm in length was transferred onto the petridish using a sterile forceps, 
onto which the colony was inoculated. 
 
 The  hair  was  incubated  at  room temperature for upto 4 weeks. A single 
strand of  hair was placed on a glass slide,mounted with LPCB, coverslip placed and 
examined under microscope. 
 
INTERPRETATION: 
 A wedge shaped perforation was considered as positive and suggestive of   
Trichophyton mentagrophytes. 
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 Absence of  wedge shape perforation was interpretated as negative and 
suggestive of Trichophyton rubrum. 
 
IDENTIFICATION OF CANDIDA SPECIES: 
Yeast and yeast like fungi were identified and speciated based on 
 
  1)GRAM STAIN  
       Presence  of  gram  positive  budding  yeast cells, hyphae and pseudo hyphae was 
noted. 
  
2) UREASE TEST  
         Christensen’s urea agar slope was used.Urea hydrolysis was interpretated as 
positive when a change of colur to pink along with growth in medium were 
observed.This test was done to differentiate between the Candida species and other 
yeasts like Malassezia Species,Trichosporon Species ,Geotrichum Species and 
Blastoschizomyces. 
 
POSITIVE NEGATIVE 
Malassezia species Candida species(except C.krusei) 
Trichosporon species Blastoschizomyces 
Candida krusei Geotrichum 
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3) GERM TUBE TEST(REYNOLDS –BRAUDE PHENOMENON) 
 This  test   was  done to  differentiate  Candida albicans  from Non-albicans 
Candida.  0.5ml of   human  serum  was  taken in a sterile test tube, into which the  
yeast colonies were suspended. The tube was incubated  at 37ºC for 2 hours in the 
incubator. After 2 hours  a loopful of suspension was placed on  a clean glass slide, a 
coverslip placed over it and examined under 40X  objective of the light microscope. 
 
INTERPRETATION: 
 Observation of germ tubes  which are  seen as a long tube–like projections with 
parallel walls and no constriction at the point of attachment to the yeast cell were 
interpreted as positive and was  presumptively identified as Candida albicans/Candida 
dubliniensis. 
 
4) CORN MEAL AGAR(DALMAU PLATE CULTURE)      
 This test was done to differentiate various species of  Candida. 
 
 A corn meal agar plate containing 1% Tween 80 was divided into four 
quadrants. The suspected yeast colony was streaked by  three parallel lines with a 
sterile straight wire onto it.A coverslip was  placed over it, such that half of the streak 
extend beyond the coveslip.Then the plates were incubated at 25ºC for 2 days. 
 
INTERPRETATION: 
 The petridish  was placed on the microscopic stage after removing the lid and 
the edge of the cover slip  was examined under 10X and 40X objectives. 
 
 The Candida species were identified based on the presence and arrangement of 
hypahe, pseudohyphae, chlamydocondia, blastoconidia and arthrocondia as follows. 
 
54 
 
 
ORGANISM BLASTOCONIDIA HYPHAE / PSEUDOHYPHAE 
C.albicans Spherical clusters at regular intervals on pseudohyphae 
Chlamydocondia present on 
hyphae 
C.tropicalis Produced randomly along hyphae Pseudohyphae present 
C.kefyr Elongated lie parallel to pseudohyphae Pseudohyphae present 
C.parapsilosis Present but not characteristic Large giant hyphae present 
C.glabrata Spherical small and tightly compacted None produced 
 
5) CARBOHYDRATE FERMENTATION TEST 
 This test was done using the peptone water fermentation test media with 2% 
sugars- Glucose,Lactose,Sucrose and Maltose. A pure colony suspension was  
inoculated  into the media  and   incubated at 30 ºC  for 3 days to 1week. The tubes 
were examined  for acid production by change in  colour to yellow and gas production 
in the durhams tube. The Candida species were identified based on the following 
fermentative pattern. 
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S.No Candida Species Glucose Maltose Sucrose Lactose 
1 C.albicans F F NF NF 
2 C.parapsilosis F NF NF NF 
3 C.tropicalis F F F NF 
4 C.pseudotropicalis F F F NF 
5 C.krusei F NF NF NF 
6 C.guilliermondii F NF F NF 
7 C.glabrata F NF NF NF 
F-Fermented; NF-Not fermented 
 
6) CARBOHYDRATE ASSIMILATION TEST(Auxanographic method) 
    Yeast nitrogen base agar media was prepared.A heavy yeast suspension was 
prepared from a 24 hour old culture in YNB and  added to 18ml of the media , 
mixed,poured in the sterile petridish.   The carbohydrate disks were applied on to the 
surface of the agar plate and incubated at 37ºC for 3 days.                     
 The various carbohydrate disks used in this study were Glucose, Maltose, 
Sucrose, Lactose, Cellobiose and Trehalose. 
INTERPRETATION:   
 Presence of growth around the carbohydrate disc was considered as positive for 
carbohydrate assimilation. 
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The Candida spp was speciated as follows: 
S.No Candida species Glu Mal Suc Lac Cel Tre 
1 C.albicans P P P N V P 
2 C.parapsilosis P P P N V P 
3 C.tropicalis P P P N P P 
4 C.pseudotropicalis P N P P V N 
5 C.krusei P N N N N N 
6 C.guilliermondii P P P N P P 
7 C.glabrata P N N N N P 
P- Positive, N-Negative, V- Variable. Glu –Glucose, Mal- Maltose,  Suc- Sucrose,  
Lac-Lactose, Cel-Cellobiose, Tre-Trehalose. 
 
7) CHROMagar CANDIDA MEDIUM 
 The yeast colonies were inoculated onto the medium and incubated at 37ºC for 
48 hours.The colour of the colonies were observed and the organism was presumptively 
identified as follows, 
SPECIES COLOUR 
C.albicans Light-green 
C.dubliniensis Dark-green 
C.glabrata Pink to purple 
C.krusei Pink 
C.parapsilosis Cream to pale pink 
C.tropicalis Blue with pink halo 
  
57 
 
 The  Candida  isolates  were speciated based on the results of the germ term 
tube test,urease test along with phenotypic characteristics on corn meal agar, 
carbohydrate fermentation and assimilation test. 
 
IDENTIFICATION OF NON-DERMATOPHYTIC MOULDS:        
MACROSCOPIC APPEARANCE:               
 The fungi were identified  based on the rate of growth, texture, pigment 
production and topography. 
 
MICROSCOPIC EXAMINATION:   
 The microscopic features of  the culture  on LPCB mount and on slide culture  
were used to identify the species. 
 
ANTIFUNGAL SUSCEPTIBILITY TESTING: 
KIRBY-BAUER DISK DIFFUSION METHOD FOR CANDIDA 
SPECIES: 
 The  antifungal susceptibility testing  were done  based on The Clinical 
Laboratory Standard Institute(CLSI) guidelines(M44-A2)[108].   
 
REAGENTS: 
 Mueller-Hinton Agar 
 2% Glucose 
 0.5µg/ml methylene blue 
 Drugs-Fluconazole,Voriconazole.  
CONTROL STRAIN: 
           Candida parapsilosis ATCC® 22019. 
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TURBIDITY STANDARD FOR INOCULUM PREPARATION 
 The  inoculum density was standardized with 0.5Mc Farland standard. 
 
INOCULUM PREPARATION 
 All the Candida isolates were subcultured onto SDA and incubated at 37ºC 
overnight. 
 Five distinct colonies were taken from the 24 hour old culture and  suspended in 
5ml of sterile saline(0.85%) .The  resulting suspension was vortexed for 15 
seconds . 
 The inoculum density was  adjusted to 0.5 Mc Farland standard at 530nm 
wavelength. 
 This adjusted yeast suspension would yield 1x106  to 5 x 106 cells/ mL. 
 
INOCULATION ONTO TEST PLATES 
 A sterile cotton swab was dipped into the yeast suspension and rotated several 
times, pressed against the wall of the tube firmly to remove the excess fluid 
from the swab. 
 The swab was streaked over Mueller-Hinton Agar with 2% glucose and 
methylene blue. 
 The antifungal disks were placed  and  plates were incubated at 37ºC for 24 
hours. 
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INTERPRETATION OF RESULTS[108]: 
The zone of inhibition was measured and  interpreted as follows. 
ANTIFUNGAL     
AGENT DISK POTENCY
ZONE DIAMETER IN 
mm RANGES 
R S-DD S 
Fluconazole 25µg ≤14 15-18 ≥19 
Voriconazole 1µg ≤13 14-16 ≥17 
 
DETECTION OF MIC BY BROTH MICRODILUTION METHOD 
 The MIC for yeasts and moulds were determined based on CLSI guildeliness 
M27-A and M38-A2 respectively[123].   
 
TEST STRAIN :  
 The MIC was determined  for  all  yeasts , filamentous moulds and 
dermatophyte  isolates . 
 
REFERENCE STRAIN:          
 Candida parapsilosis ATCC® 22019 –For Candida species and dermatophytes. 
 Aspergillus flavus ATCC® 204304 – For filamentous fungi. 
 
ANTIFUNGAL AGENTS USED:  
 Terbinafine, Itraconazole, Ketoconazole and Fluconazole were used for 
dermatophytes. Itraconazole, Ketoconazole, Fluconazole and Voriconazole  were used 
for Candida species and filamentous fungi. 
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RANGE OF DRUG CONCENTRATIONS  TESTED: 
 Terbinafine     -  0.0313 to 16 µg/ml 
 Itraconazole     -  0.0313 to 16 µg/ml  
 Ketoconazole   -  0.0313  to 16 µg/ml  
 Voriconazole   -   0.0313  to 16 µg/ml 
 Fluconazole     -  0.125 to  64 µg/ml. 
 
SOURCE OF DRUG: 
 All the drugs were obtained from The Global pharmacuetical pvt ltd,Chennai. 
 
WEIGHING OF ANTIFUNGAL DRUGS 
 The weight of anti-fungal drugs were calculated according to the following 
formula. 
 
Volume(ml) X Concenteration(μg/ml) 
Weight(mg) =    ------------------------------------------------ 
                                  Assay  Potency (μg/mg) 
 
REAGENTS:  
 A  2 day / 7 day old culture for inoculum preparation was  used for Candida 
species and moulds respectively.  
 Tween 20   
 0.85%Normal saline 
 Buffer  - MOPS (3-(N-morpholino) prophanesulfonic acid 
 RPMI 1640 medium- (RoseWell Park Memorial Institute)  
 with glutamine, without bicarbonate and with phenol red as 
indicator(Himedia,Mumbai,India.) 
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 100% DMSO(dimethyl sulfoxide) was used to dissolve water insoluble 
drugs like terbinafine,itraconazole,ketoconazole and voriconazole. 
 Sterile microtiter plate 
 Distilled water  was used to dissolve water soluble  drug  fluconazole.  
 
INOCULUM PREPARATION 
A) FILAMENTOUS  FUNGI 
1) The isolates were  subcultured onto the   Potato Dextrose Agar  for 7 days to 
induce conidia formation. 
2) The 7 day old colonies  were then covered with 2ml of sterile 0.85%Normal 
Saline and a drop of TWEEN 20(0.01ml) was added.Then the colonies were 
gently probed with the pipette. 
3) The resulting  mixture of conidia  was transferred  into a sterile tube.The 
heavier particles were allowed  to settle  down for 3 to 5 mins. 
4) The supernatant was transferred  into a sterile tube ,cap tightened  and  mixed 
with vortex mixer for 15 seconds. 
5) The resulting inoculum was read and adjusted to optical density of range 0.09 to 
0.11(80 to 82% of transmittance) for Aspergillus species,0.15 to 0.17 for 
Syncephalastrum and Fusarium species,0.25 to 0.3 for Bipolaris species using a 
spectrophotometer  . 
6) The resulting suspension was further diluted 1:50 with the standard medium.   
So that the final inoculum would correspond to 0.4  X 104  to 5 X104 cfu/ml. 
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B) CANDIDA SPECIES 
1) The test strains were subcultured onto  SDA and incubated at 35ºC for 24 hours. 
2) From the 24 hour old culture, 5 colonies were picked and suspended in 5ml of  
sterile normal saline(0.85%). 
3) The suspension was  vortexed for 15 seconds. 
4) The resulting  suspension was  adjusted to 0.5 Mc Farland Standard at 530 nm 
wavelength with a spectrophotometer. 
5) The resulting suspension was further diluted 1:50 with the standard medium so 
that the test inoculum was 1 X 103  to 5 X 103 CFU/ml. 
 
DRUG POWDER PREPARATION: 
 For water soluble drug fluconazole stock solution is prepared with sterile 
distilled water in the concentration of 5120 μg/ml. 
 For water insoluble drug itraconazole,ketoconazole,voriconazole and 
terbinafine, stock solution is prepared with DMSO in the concenteration of 
1600 μg/ml.  
 
A)WATER INSOLUBLE DRUG: 
DRUG SET PREPARATION: 
 Water insoluble drugs namely Itraconazole,Voriconazole,Ketoconazole and 
terbinafine were dissolved in DMSO and  the intermediate drug concenterations were 
prepared  as  follows. 
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DRUG SET PREPARATION: 
ROW 1 
TUBES 
1 
(STO
CK) 
2 3 4 5 6 7 8 9 10 
AMOUNT 
OF DMSO(ml) - 0.5 1.5 3.5 0.5 1.5 3.5 0.5 1.5 3.5 
AMOUNT 
OF DRUG(ml) 
(0.5ML) 
- 
FR
O
M
 T
U
B
E 
1 
FR
O
M
 T
U
B
E 
1 
FR
O
M
 T
U
B
E 
1 
FR
O
M
 T
U
B
E 
4 
FR
O
M
 T
U
B
E 
4 
FR
O
M
 T
U
B
E 
4 
FR
O
M
 T
U
B
E 
7 
FR
O
M
 T
U
B
E 
7 
FR
O
M
 T
U
B
E 
7 
INTERMEDIATE 
DRUG 
CONCENTERATI
ON(μg/ml) 
IN ROW 1 
1600 800 400 200 100 50 25 12.5 6.25 3.13 
    
The final drug concentrations were prepared by diluting in RPMI as follows.      
ROW 2 
TUBES 1 2 3 4 5 6 7 8 9 10 
AMOUNT  OF 
RPMI IN ml 4.9 4.9 4.9 4.9 4.9 4.9 4.9 4.9 4.9 4.9 
ADD DRUG FROM 
CORRESPONDING 
ROW(1) 
TUBES(1-10)(in μl) 
100 100 100 100 100 100 100 100 100 100 
 
FINAL DRUG 
CONCENTERATIO
N(μg/ml)  IN ROW 
(2) TUBES 
32 16 8 4 2 1 0.5 0.25 0.125 0.0625 
 
 The finally diluted variable concenteration of drugs  were added to the diluted 
inoculum as follows.             
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DRUG WITH INOCULUM PREPARATION: 
 
MICROTITER 
PLATE WELLS 
(COLUMNS) 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
FROM ROW 2 
TUBES ADD DRUG 
WITH RPMI TO 
MICROTITER 
PLATE(μl) 
 
 
100 
 
 
100
 
 
100
 
 
100
 
 
100 
 
 
100 
 
 
100 
 
 
100 
 
 
100 
 
 
100 
 
ADD INOCULUM 
TO PLATE (μl) 
 
100 
 
100
 
100
 
100
 
100 
 
100 
 
100 
 
100 
 
100 
 
100 
 
 
FINAL DRUG 
CONCENTRATION 
IN WELL(μg/ml) 
 
16 
 
8 
 
4 
 
2 
 
1 
 
0.5 
 
0.25
 
0.125 
 
0.062 
 
0.0313 
 
 
 Growth control was added to column 11,with 100μl of RPMI and  100μl of 
inoculum.Drug  control was added to column 12 with 100μl of RPMI and 100μl of 
drug.   
 
INCUBATION: 
 The microtiter plates were incubated at 35°C for 24 hours for  Candida species 
and 48 hours for  filamentous fungi. 
 
 For dermatophytes the microtiter plates  were  incubated  at 28ºC  for 4 to 5 
days[70],[77].  
  
65 
 
 
B)WATER SOLUBLE DRUG: 
DRUG SET PREPARATION:   
 Stock solution was prepared by dissolving the water soluble drug fluconazole in 
distilled water.A serious of intermediate drug concenterations were prepared with 
RPMI as follows. 
 
ROW 1 
TUBES 1 2 3 4 5 6 7 8 9 10 
AMOUNT OF 
RPMI (ml) 7 1 3 1 1.5 3.5 1 1.5 3.5 1 
 
 
AMOUNT 
OF DRUG(ml) 
 
FROM 
STOCK 
FROM 
TUBE 
1 
FROM 
TUBE 
1 
FROM 
TUBE 
3 
FROM 
TUBE 
3 
FROM 
TUBE 
3 
FROM 
TUBE 
6 
FROM 
TUBE 
6 
FROM 
TUBE 
6 
FROM 
TUBE 
9 
1 1 1 1 0.5 0.5 1 0.5 0.5 1 
 
INTERMEDIAT
E 
DRUG 
CONCENTERA
TION(μg/ml) 
IN ROW 1 
640 320 160 80 40 20 10 5 2.5 1.25  
 
 The final concenteration of drug was prepared from the intermediate drug 
concenteration by diluting in RPMI medium(1:50) as follows. 
 
ROW 2  TUBES 1 2 3 4 5 6 7 8 9 10 
AMOUNT OF RPMI 
IN ml 4 4 4 4 4 4 4 4 4 
4 
 
ADD DRUG FROM 
CORRESPONDING 
ROW 1 TUBES(1-
10)(ml) 
1 1 1 1 1 1 1 1 1 1 
FINAL   DRUG 
CONCENTERATION 
(μg/ml)   IN ROW 2 
TUBES 
 
128 
 
64 
 
32 
 
16 
 
8 
 
4 
 
2 
 
1 
 
0.5 
 
0.25 
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 The finally diluted  variable concentration of drugs were added to the diluted 
inoculum as follows. 
 
DRUG WITH INOCULUM PREPARATION: 
MICROTITER 
PLATE WELLS 1 2 3 4 5 6 7 8 9 10 
FROM ROW 2 
TUBES ADD DRUG 
TO MICROTITER 
PLATE(μl) 
100 100 100 100 100 100 100 100 100 100 
ADD INOCULUM 
TO PLATE (μl) 100 100 100 100 100 100 100 100 100 100 
FINAL DRUG 
CONCENTRATION 
IN WELL(μg/ml) 
64 32 16 8 4 2 1 0.5 0.25 0.125 
 
    Growth  control was added to column 11,with 100μl of RPMI and  100μl of 
inoculum.Drug  control was added to column 12 with 100μl of RPMI and 100μl of 
drug.   
 
INCUBATION: 
 The microtiter plate was incubated at 35°C for 24 hours for Candida species 
and 48 hours for filamentous fungi. 
 
 For dermatophytes the microtiter plate  was incubated at 28ºC for 4 to 5 
days[70][77]. 
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READNG OF RESULTS: 
 The growth in each of the microtiter well was compared with that of the growth 
control and scored as follows. 
 
1) Optically clear absence of growth 
2) Approximately 25% of the growth control  or Slight growth. 
3) Approximately  50% of the growth control or Prominent reduction in growth. 
4) Approximately as of the growth medium  or Slight reduction in the growth.  
5) No reduction in the growth. 
 
INTERPRETATION: 
 MIC for terbinafine was determined by noting 100% inhibition of growth 
control and that for azoles by noting 80% growth inhibition.                         
 
 The MIC 50 and MIC 90 of the isolates were determined[118].   
 
  For Candida species[123] , the interpretation of MIC in (μg/ml) was as follows. 
Drug Susceptible (μg/ml) 
Susceptible-Dose 
Dependent (μg/ml) 
Resistant 
(μg/ml) 
Fluconazole ≤8 16-32 ≥64 
Itraconazole ≤0.125 0.25-0.5 ≥1 
Voriconazole ≤1 2 ≥4 
 
STATISTICAL ANALYSIS: 
 Statistical analysis was done by using  Statistical Package for Social 
Sciences(SPSS) version 21 .The test  used in this study was Pearson’s Chi Square 
analysis test . P value <0.05 is considered as statistically significant. 
  
 
 
 
 
 
 
RESULTS 
  
68 
 
RESULTS 
 A total of 175 patients were included in the study and samples of nail scrapings 
were collected and processed. The details of the study population is as follows.  
 
TABLE.1: AGE AND GENDER  DISTRIBUTION (n=175) 
AGE(YEARS) MALE FEMALE TOTAL 
21-30 2 - 2(1.14%) 
31-40 10 7 17(9.72%) 
41-50 21 31 52(29.72%) 
51-60 27 35 62(35.43%) 
61-70 24 9 33(18.85%) 
71-80 7 2 9(5.14%) 
TOTAL 91(52%) 84(48%) 175(100%) 
 
 Among the175 patients, majority of patients were in the age group of 51 – 60 
years (35.43%) in both sexes. The mean age was observed to be 52.8 years .  
 
 The study population consisted of  52% males and 48% females in the ratio of  
1.08 :1. 
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TABLE. 2 : DISTRIBUTION OF  OCCUPATION (n=175) 
OCCUPATION MALE FEMALE TOTAL PERCENTAGE 
FARMERS 52 25 77 44 
HOUSEWIVES NA 46 46 26.28 
CARPENTER 7 0 7 4 
DRIVER 7 0 7 4 
WATCHMAN 7 0 7 4 
SHOPKEEPER 5 1 6 3.42 
TAILOR 5 1 6 3.42 
CLERICAL STAFF 3 3 6 3.42 
ENGINEER 4 2 6 3.42 
STAFF NURSE 0 5 5 2.9 
SWEEPER 1 1 2 1.14 
TOTAL 91 84 175 100 
NA-Not applicable.          
 
  Among the study population, 44% of  them were farmers and  26.28% were  
housewives.  
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TABLE.3: DISTRIBUTION OF TYPE OF DIABETES MELLITUS IN    STUDY     
POPULATION(n=175) 
TYPE OF 
DIABETES NO.OF.PATIENTS PERCENTAGE 
TYPE I 14 8 
TYPE II 161 92 
TOTAL 175 100 
       
 Among the patients with onychomycosis,92% had type II diabetes mellitus 
(n=161) and  8% had  type I diabetes mellitus (n=14).  
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TABLE.4: DISTRIBUTION OF CLINICAL PATTERN OF 
ONYCHOMYCOSIS(n=175) 
CLINICAL 
TYPE 
FINGER 
NAIL TOE NAIL 
BOTH 
NAIL TOTAL 
DLSO 25 109 22 156(89.5%) 
PSO 1 0 1 2(1.14%) 
TDO 0 10 7 17(9.7%) 
TOTAL 26(15%) 119(68%) 30(17%) 175(100%) 
 
 Among 175 patients, 156 (89.5%) had  DLSO (Distal lateral subungual 
onychomycosis). TDO (Total Dystrophic Onychomycosis)was present in 17(9.7%) and 
PSO(Proximal Subungual Onychomycosis) in 2 (1.14%) patients.  
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TABLE.5 : DETAILS OF SITE OF ONYCHOMYCOSIS(n=175) 
SITE MALE FEMALE TOTAL 
FINGER 13 13 26(15%) 
TOE 62 57 119(68%) 
BOTH 16 14 30(17%) 
TOTAL 91 84 175(100%) 
       
        Toe  nails were predominantly involved in 68% of cases (n= 119) in both sexes 
while finger nails were involved in 15% of  patients  (n=26) .   Both toe and finger nails 
were affected in 17% of patients(n=30) . 
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TABLE.6: DURATION OF ONYCHOMYCOSIS(n=175) 
DURATION MALE FEMALE TOTAL PERCENTAGE 
Upto 1year 32 22 54 30.86% 
>1year-5year 47 45 92 52.57% 
>5year 12 17 29 16.57% 
TOTAL 91 84 175 100% 
 
 Majority of the patients, (52.57%) gave  history of nail involvement for a 
duration of  1 to 5years (n=92).30.86% had nail affliction for less than 1year(n=54) and 
16.57 % had a duration of more than 5 years (n=29) . 
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TABLE.7 :  SEVERITY OF ONYCHOMYCOSIS(n=175) 
DEGREE TOTAL PERCENTAGE 
MILD 152 87% 
MODERATE 5 3% 
SEVERE 18 10% 
TOTAL 175 100% 
   
 Among the study population,87%(n=152) of the  patients had mild 
onychomycosis. 10%(n=18) of  patients  had  severe onychomycosis   and      3%(n=5)  
had  moderate  degree of onychomycosis.  
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TABLE.8:  CORRELATION OF SEVERITY OF ONYCHOMYCOSIS  
WITH TYPE OF DIABETES MELLITUS(n=175). 
TYPE OF DM MILD MODERATE SEVERE TOTAL 
Type I 13(7.5%) 0 1(0.5%) 14(8%) 
Type II 139(79.5%) 5(3%) 17(9.5%) 161(92%) 
TOTAL 152(87%) 5(3%) 18(10%) 175(100%) 
  
 Mild and severe onychomycosis were present in 79.5% and 9.5% of type II 
diabetes mellitus patients respectively.There was no statistical significance between the 
severity of onychomycosis and type of diabetes mellitus. (p=0.725).    
 
CORRELATION OF SEVERITY OF ONYCHOMYCOSIS WITH TYPE OF 
DIABETES MELLITUS(n=175) 
 
  
MILD MODERATE SEVERE
Type I Type II
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TABLE.9 : CORRELATION OF SEVERITY OF ONYCHOMYCOSIS WITH  
DURATION OF DIABETES MELLITUS (n=175) 
DURATION MILD MODERATE SEVERE TOTAL 
Less than 
1 year 32(18.3%) 0 5(2.9%) 37(21.2%) 
1-5 years 54(30.9%) 3(1.7%) 4(2.3%) 61(34.9%) 
5-10years 51(29.2%) 2(1.3%) 8(4.4%) 61(34.9%) 
10-15years 15(8.6%) 0 1(0.4%) 16(9%) 
TOTAL 152(87%) 5(3%) 18(10%) 175(100%) 
 
 Majority  of the patients had  a history of diabetes mellitus  for  a duration of    1 
to 5 years  (34.9%)   and 5 to 10 years (34.9%). Among 18 patients with severe 
onychomycosis,4.4% (n=8) had  diabetes mellitus for a duration of 5-10 years.There 
was no statistical significance between the severity of onychomycosis and the duration 
of  diabetes mellitus(p=0.600).  
 
CORRELATION OF SEVERITY OF ONYCHOMYCOSIS WITH  DURATION 
OF DIABETES MELLITUS(n=175) 
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TABLE.10 : CORRELATION OF SEVERITY OF ONYCHOMYCOSIS WITH  
BLOOD SUGAR LEVELS (n=175) 
BLOOD SUGAR  
LEVELS 
(mg/dl) 
MILD MODERATE SEVERE TOTAL 
100-200 131 (75.05%) 
5 
(3%) 
17 
(9.6%) 
153 
(87.65%) 
201-300 16 (8.95%) 0 
1 
(0.4%) 
17 
(9.35%) 
301-400 5 (3%) 0 0 
5 
(3%) 
TOTAL 152(87%) 5(3%) 18(10%) 175 (100%) 
 
 Most of the patients(87.65%) had blood sugar levels in the range of 100 to 
200mg/dl and among  them 75.05%  had mild degree of onychomycosis. There was no 
statistical significance  between  the  severity of onychomycosis and the blood sugar 
level (p=0.679).  
 
CORRELATION OF SEVERITY OF ONYCHOMYCOSIS WITH  BLOOD 
SUGAR LEVELS(n=175)  
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TABLE.11: RESULTS OF CULTURE AND KOH MOUNT(n=175) 
 
METHOD POSITIVE NEGATIVE 
KOH mount 123(70.29%) 52(29.71%) 
CULTURE 81(46.28%) 94(53.72%) 
 
 The culture positivity rate was 46.28% and the rate of detection by KOH mount 
was 70.29%. 
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TABLE.12: EVALUATION OF CULTURE AND KOH(n=175) 
KOH 
POSITIVE  
CULTURE 
POSITIVE 
KOH 
NEGATIVE 
CULTURE 
POSITIVE 
KOH 
POSITIVE 
CULTURE 
NEGATIVE 
KOH 
NEGATIVE 
CULTURE 
NEGATIVE 
77(44%) 4(2.29%) 46(26.29%) 48(27.42%) 
 
 Among 175 patients, 4 patients (2.29%) were culture positive, but potassium 
hydroxide mount negative and 26.29% of  patients were potassium hydroxide mount 
positive but culture negative. 
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TABLE.13: DISTRIBUTION OF FUNGAL ISOLATES:(n=81) 
ISOLATES DLSO TDO TOTAL PERCENTAGE 
DERMATOPHYTES 18 3 21 25.92% 
CANDIDA SPECIES 30 2 32 39.50% 
NON-
DERMATOPHYTIC 
MOULDS 
26 2 28 34.58% 
TOTAL 74 91.35% 
7 
8.65% 81 100% 
 
 Candida species was the most common isolate( 39.50%),followed by non-
dermatophytic moulds (34.58%) and dermatophytes (25.92%). Majority of the isolates 
(91.35%)were associated with DLSO type of onychomycosis. 
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TABLE.14: DISTRIBUTION OF CANDIDA ISOLATES(n=32) 
 
ISOLATES NUMBER PERCENTAGE 
C.albicans 8 25% 
C.parapsilosis 20 62.5% 
C.tropicalis 4 12.5% 
TOTAL 32 100% 
    
 Among the Candida species ,C.parapsilosis(62.5%)  was the most        common 
species followed by C.albicans(25%) and C.tropicalis(12.5%).   
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TABLE  15: EPIDEMIOLOGICAL  PATTERN  IN  CANDIDIAL 
ONYCHOMYCOSIS:(n=32) 
 
EPEDIMEMIOLOGICAL 
VARIABLE NUMBER PERCENTAGE 
AGE 
30 to 50 years   13 40.62% 
Above 50 years  19 59.38% 
SEX 
Male    11 34.38% 
Female   21 65.62% 
OCCUPATION 
Farmer   12 37.5% 
Housewives   10 31.25% 
Watchman   3 9.38% 
Clerical staff   2 6.25% 
Driver    2 6.25% 
Others    3 9.37% 
NAIL INVOLVEMENT 
Finger nail    14 43.75% 
Toe nail        13 40.62% 
Both nails     5 15.63% 
TYPE 
DLSO    30 93.75% 
TDO      2 6.25% 
OTHER COMORBID 
CONDITIONS 
Hypertension    7 21.88% 
H/O trauma  4 12.5% 
H/o frequent  
handwashing  2 6.25% 
 
 The frequency of  Candida species was more common among the age group 
above 50years(59.38%)  and  in females(65.62%).  37.5% were farmers and 31.25% 
were housewives. Finger nails were involved in 43.75% of patients. Among the patients 
with candidal onychomycosis ,93.75% of patients had DLSO  type of onychomycosis. 
21.88% of patients had hypertension.There was H/O trauma in 12.5% of patients. 
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TABLE.16: DISTRIBUTION OF NON-DERMATOPHYTIC MOULDS(n=28). 
ISOLATES TOTAL PERCENTAGE 
A.niger 3 10.71% 
A.fumigatus 4 14.27% 
Fusarium species 16 57.14% 
Syncephalastrum species 1 3.58% 
Penicillium species 1 3.58% 
Absidia species 1 3.58% 
Bipolaris species 2 7.14% 
TOTAL 28 100% 
 
 Among  non-dermatophytic  moulds,  Fusarium species  was the most  common  
etiological agent (57.14%), followed   by  Aspergillus fumigates (14.27%), Aspergillus 
niger (10.71%), Bipolaris species (7.14%),  Absidia species (3.58%) ,Penicillium 
species(3.58%) and Syncephalastrum species (3.58% ). 
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TABLE.17: EPIDEMIOLOGICAL PATTERN IN  
NON-DERMATOPHYTIC ONYCHOMYCOSIS (n=28) 
 
EPEDIMEMIOLOGICAL 
VARIABLE NUMBER PERCENTAGE 
AGE 
35 to 50 years   11 39.28% 
Above 50 years  17 60.72% 
SEX 
Male    17 60.72% 
Female   11 39.28% 
OCCUPATION 
Farmer   14 50% 
Housewives    4 14.28% 
Tailor    4 14.28% 
Carpenter   2 7.14% 
Driver    2 7.14% 
Others    2 7.14% 
NAIL INVOLVEMENT 
Finger nail    3 10.72% 
Toe nail        21 75% 
Both nails     4 14.28% 
TYPE 
DLSO    26 92.86% 
TDO      2 7.14% 
OTHER COMORBID 
CONDITIONS 
Hypertension    3 10.72% 
H/O trauma  6 21.43% 
CKD      2 7.14% 
H/o frequent handwashing   2 7.14% 
 
 The nondermatophytic moulds  were more common  among  the age  group  
above 50years (60.72%)  and  in males (60.72%).  50 % of the patients  were farmers 
and 14.28% were housewives.  Toe nails  were  involved  in 75 % of patients. Among  
the  patients  with  non-dermatophytic mould infection, 92.86% of patients had DLSO  
type of onychomycosis. 21.43% of patients had trauma and 10.72% of the patients  had  
hypertension. 
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TABLE.18:DISTRIBUTION OF DERMATOPHYTE ISOLATES IN STDUY 
POPULATION (n=21) 
 
ISOLATE TOTAL PERCENTAGE 
T.rubrum 13 61.90% 
T.tonsurans 6 28.58% 
E.floccosum 1 4.76% 
M.gypseum 1 4.76% 
TOTAL 21 100% 
     
 Among  the  dermatophytes, the  most  common  isolate  was Trichophyton 
rubrum (61.90%),  followed  by Trichophyton tonsurans  (28.58%),   Epidermophyton 
floccosum (4.76%)  and  Microsporum gypseum (4.76% ).  
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TABLE.19:DISTRIBUTION OF DERMATOPHYTES  
IN EXTRAUNGUAL SITES 
 
ISOLATE Trunk /Face/head Groin Feet Hand 
NO.OF 
ISOLATES 
Trichophyton 
rubrum(n=13) 
5 
(38.46%) 
1 
(16.66%) 0 0 
5 
(38.46%) 
Trichophyton 
tonsurans(n=6) 
1 
(16.66%) 
1 
(16.66%) 
2 
(33.33%) 0 
5 
(83.33%) 
Microsporum 
gypseum(n=1) 0 0 0 0 0 
Epidermophyton 
floccosum(n=1) 
1 
(100%) 
1 
(100%) 0 0 
1 
(100%) 
 
 Tinea corporis  was  found to be associated with 38.46% of  T.rubrum  
infection. Tinea pedis was found to be the associated with 33.33% of T.tonsurans. The 
single isolate of Epidermophyton floccosum was found to be associated with both  tinea 
corporis and tinea cruris. 
 
TABLE.20:SUSCEPTIBILITY PATTERN OF CANDIDA ISOLATES BY DISK 
DIFFUSION METHOD 
ISOLATE NO OF ISOLATES FLUCONAZOLE VORICONAZOLE 
C.parapsilosis 20 20(100%) 20(100%) 
C.albicans 8 8(100%) 8(100%) 
C.tropicalis 4 4(100%) 4(100%) 
 
All  the  Candida  species  were  susceptible  to  both  fluconazole  and voriconazole.  
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TABLE 21 : MIC OF CANDIDA SPECIES BY MICROBROTH  
DILUTION METHOD 
 
CANDIDA 
SPECIES 
 
 
No 
 
FLU 
(64-.125) 
μg/ml 
KET 
(16-.031) 
µg/ml 
ITRA 
(16-0.0313) 
μg/ml 
VORI 
(16-0.0313) 
μg/ml 
MIC   
50 
MIC
90 
MIC
50 
MIC
90 
MIC 
50 
MIC 
90 
MIC 
50 
MIC 
90 
C.parapsilosis 20 1 2 0.5 1 0.062 0.125 0.0313 0.0313 
C.albicans 8 1 2 0.5 1 0.062 0.125 0.0313 0.0313 
C.tropicalis 4 1 2 0.5 1 0.062 0.125 0.0313 0.0313 
 
FLU-Fluconazole,KET–Ketoconazole,ITRA–Itraconazole,VORI- Voriconazole 
 
 The  MIC of  Candida  species  were  within the following range as follows:   
Fluconazole: 1- 2 μg/ml, Ketoconazole:0.5-1 μg/ml,  
 
Itraconazole:0.0625 – 0.125 μg/ml  and   Voriconazole:0.0313 μg/ml .   
 
 All of the isolated Candida speciess were sensitive to fluconazole,itraconazole 
and voriconazole by MIC determination. 
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TABLE.22:ANTIFUNGAL SUSCEPTIBILITY PATTERN OF 
NON-DERMATOPHYTIC MOULDS 
 
ISOLATES No 
FLU 
(64-0.125) 
μg/ml 
KET 
(16-0.0313) 
μg/ml 
ITRA 
(16-0.0313) μg/ml 
VORI 
(16 - 0.0313) μg/ml 
MI
C 
50
MI
C 
90
MI
C 
50 
MI
C 
90
MIC 
50 
MIC 
90 
MIC 
50 
MIC 
90 
Absidia species  1 
 
16 
 
16 
 
8 
 
8 
 
4 
 
4 
 
1 
 
1 
Syncephalastru
m species 
 
1 
 
4 
 
4 
 
0.5 
 
0.5 
 
0.0625 
 
0.0625 
 
0.0313 
 
0.0313
Penicillium 
species 
 
1 
 
1 
 
1 
 
8 
 
8 
 
1 
 
1 
 
0.0313 
 
0.0313
 
Bipolaris 
species 
 
2 
 
8 
 
8 
 
2 
 
4 
 
1 
 
1 
 
0.0625 
 
0.0625
 
A.niger 
 
3 
 
4 
 
8 
 
1 
 
2 
 
0.5 
 
1 
 
0.0313 
 
0.0313
 
A.fumigatus 
 
4 
 
16 
 
32 
 
0.5 
 
2 
 
0.5 
 
0.5 
 
0.0313 
 
0.0313
 
Fusarium 
species 
 
16 
 
32 
 
64 
 
16 
 
32 
 
8 
 
16 
 
4 
 
8 
FLU-Fluconazole,KET–Ketoconazole,ITRA–Itraconazole,VORI-Voriconazole.          
 
The MIC range of  the various non-dermatophytic moulds were as follows: 
 Fluconazole: 1 -64  μg/ml,  Ketoconazole: 0.5 - 32 μg/ml 
 Itraconazole: 0.0625- 16 μg/ml  and   Voriconazole: 0.0313– 8 μg/ml. 
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TABLE.23:ANTIFUNGAL SUSCEPTIBILITY PATTERN OF 
DERMATOPHYTES 
 
 
ISOLATES 
 
 
No 
 
FLU 
(64-0.125) 
μg/ml 
KET 
(16 -0.0313) 
μg/ml 
ITRA 
(16 -0.0313) 
μg/ml 
TERBI 
(16 -0.0313) 
μg/ml 
MIC
50 
MIC
90 
MIC
50 
MIC
90 
MIC
50 
MIC
90 
MIC 
50 
MIC 
90 
Trichophyton 
rubrum 13 8 32 0.5 2 0.25 0.5 0.0313 0.0313 
Trichophyton 
tonsurans 6 4 8 0.5 2 0.25 1 0.0313 0.0313 
Microsporum 
gypseum 1 8 8 2 2 1 1 0.0313 0.0313 
Epidermophyton 
floccosum 1 16 16 1 1 0.5 0.5 0.0313 0.0313 
 
FLU-Fluconazole, KET – Ketoconazole, ITRA – Itraconazole,TERBI- Terbinafine. 
 
The MIC range of dermatophytes were as follows:    
           Fluconazole:4-32μg/ml 
           Ketoconazole: 0.5-2μg/ml 
           Itraconazole:0.25-1μg/ml and 
           Terbinafine:0.0313μg/ml .   
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CORN MEAL AGAR-C.tropicalis 
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MACROSCOPIC APPEARANCE OF 
Trichophyton rubrum 
OBVERSE –powdery.  REVERSE (RED PIGMENTATION) 
 
 
 
MICROSCOPIC APPEARANCE 
- Pencil Shaped Macroconidia 
 
 
  
MACROSCOPIC APPEARANCE - Trichophyton tonsurans 
OBVERSE –White coloured,powdery        REVERSE-yellow brown 
 
  
 
MICROSCOPIC APPEARANCE 
-Varying shapes of microconidia 
 
 
 
MACROSCOPIC APPEARANCE -  Microsporum gypseum 
OBVERSE –Buff coloured,powdery.  REVERSE-Orange brown 
 
  
 
MICROSCOPIC APPEARANCE 
Microconidia and macroconidia(2 to 6 celled) 
 
 
 
MACROSCOPIC APPEARANCE - Epidermophyton floccosum 
OBVERSE-Khaki coloured,powdery.      REVERSE-yellow-brown 
 
 
MICROSCOPIC APPEARANCE 
Club shaped macroconidia in clusters 
 
 
  
MACROSCOPIC APPEARANCE OF Fusarium species 
OBVERSE (Cottony,Pink coloured)   REVERSE 
 
  
 
MICROSCOPIC APPEARANCE  -Sickle shaped macroconidia 
 
 
 
  
MACROSCOPIC APPEARANCE- Syncephalustrum  species 
OBVERSE –Cottony,gray black.  REVERSE 
 
  
 
MICROSCOPIC APPEARANCE-globular vesicle supporting merosporangium 
 
 
 
  
MACROSCOPIC APPEARANCE OF Bipolaris species 
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DISCUSSION 
 
 Onychomycosis is not only a cosmetic problem among diabetics but also  a 
potential  health  problem  among  them. Higher frequency of diabetic foot 
disorders,lower limb amputations are common among diabetic patients than those 
diabetic patients without onychomycosis[10,98]. 
 
 A total of 175 diabetic patients who attended the  Out patient clinic of  the 
Departments of Diabetology and  Dermatology,Rajiv Gandhi Government General 
Hospital,who were diagnosed with onychomycosis were included in this study  for a 
period of one year.          
 
 Both  male and females  in  the  age group of  24 to 78 years were included in 
the study.  The majority of the  patients(35.43%) were in the age group of 51 – 60 years 
[TABLE.1] .  This is similar to  the  study  by Al-Mutairi et al who reported 
onychomycosis to be the commonest in the age group of  56 to 65 years[98].   Gupta et 
al and Saunte et al also  have reported a higher prevalence of onychomycosis among 
the elderly diabetic patients[12][16]. 
 
 In our study  onychomycosis among  males (52%) was only marginally higher  
than females (48%)  in the ratio of 1.08:1[TABLE.2]. This  can be attributed  to the 
increase in  health awareness among  women and  their  positive attitude towards   
treatment  and  increased cosmetic consciousness[99]. Higher  incidence among  males 
were  noted  in several studies[98][12][14]. This  may be due to the higher  outdoor 
activites  among  males who were also more prone to trauma[102].              
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 The proportion of onychomycosis among patients in various occupations was 
analysed.   It was observed  that 44%  of the patients were farmers and 26.28%  were 
housewives. Such increased incidence  is due to increased perspiration,  greater risk of 
occupation  related trauma  and exposure to soil saprophytes. Farmers are more  
commonly involved due to nail trauma as a result of farming and manual labour which  
will lead to inoculation and growth of  fungi causing onychomycosis[23].  
 
 In  our  study,  92% of  study  population  had  Type II diabetes mellitus 
[TABLE.3]. The most common clinical presentation of onychomycosis was  DLSO  
(89.5%),  followed by  TDO (9.7%)  and  PSO  (1.14%) [TABLE.4].  This is consistent 
with the study by  Al-Mutairi et al [98]  and  Romano C et al[122]  who  reported  the  
most common  presentation as DLSO.They  also observed that type II  diabetes mellitus 
patients were more common in their study. 
 
 In our study 68% of diabetic patients had toe nail involvement followed by  
both nails (17%) and finger nails (15%) [TABLE.5]. This is consistent with a study 
fom India[14] and Kuwait[98]who reported a similar frequency  of occurrence in toe nails. 
Further it was observed that the great toe nail was the most common site probably due 
to   the  bigger size predisposing to increased trauma[107]. 
 
 Conversely, some authors have reported  a predominant involvement of finger 
nails[102].  Increased   incidence  of  finger nail onychomycosis may be due to increased 
likelihood of occupation  related trauma. Finger nail onychomycosis is also more likely 
than  toe nail onychomycosis  to arouse      the patients’ concern, driving them to seek  
medical attention[102].    
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 In our study, the duration of OM varied between 1 month to more than 5 years. 
Majority of  the patients (52.57%), gave the  history of nail involvement for  a duration 
of 1 to 5 years. [TABLE.6].  The mean duration of OM among the study population 
was 4.4 years. A study  by   Al-Mutairi et al[98]  reported that the mean duration of OM 
was 1.8 years.  
 
 In our study, 87% of the  patients had mild onychomycosis and  10%   of  
patients  had  severe  onychomycosis [TABLE.7].  The severity of onychomycosis  
varies in different studies.Severe onychomycosis was reported  in 32.5% and 4.4% by 
Gupta et al[16]  and Al-Mutairi et al [98]respectively. 
 
 In our study, there  was no statistically   significant  correlation       between  the  
severity of onychomycosis and  type of diabetes mellitus (p=0.725)[TABLE.8]. This is 
well correlated with the study of Saunte DM et al[12]  and Al-Mutairi et al [98].     
 
 Majority  of the patients had a  history of diabetes mellitus  for  a duration of  1 
to 5 years(34.9%) and 5 to 10 years (34.9%). There was no statistically significant 
correlation between  the  severity  of  onychomycosis  and  the  duration  of   diabetes 
mellitus(p=0.600)[TABLE.9].This is similar to the  observation by Leelavathi et al in 
Malaysia [100] ,Suhelya et al [94]  and Noorbala[95]. But  Al-Mutairi et al [98]  and Dogra S 
et al[14]   reported a  siginficant increase in the severity of onychomycosis with longer 
duration of diabetes mellitus. 
 
 There  was no statistically significant correlation between the severity of 
onychomycosis  and  blood glucose levels  of  patients with diabetes mellitus in our 
study (p=0.679) [TABLE.10]. This is  also similar to the  studies by   Al-Mutairi et al 
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[98] , Dogra S et al[14]  and  Glucan A et al[105] who found a similar lack of correlation 
between the two variables. 
 
 A study by  Romano C et al[122]  also   reported  that  there was no  significant 
correlation between dermatophytosis and type or  duration of diabetes and blood 
glucose levels.       
 
 In our study, the culture positivity rate was 46.28% and the rate of detection in 
KOH mount was 70.29%[TABLE.11]. A study by Karmakar S et al [110] reported an 
isolation rate of 41.6% .Our isolation rate is also similar to a  study  by Ahuja et al[106]  
who reported an isolation rate of 39.5% among OM.  A  lower culture positivity rate of 
29% and 20%  was observed by Gupta et al.,  and Malik et al[106] respectively. 
 
 In our study,2.29% of patients samples were culture positive but potassium 
hydroxide(KOH)  mount negative and 26.29% of cases were KOH mount positive but 
culture negative[TABLE.12]. A study  by Al-Mutairi et al [98] reported   that 18.6% 
were culture positive but   KOH mount  negative and  11.6% potassium hydroxide 
mount positive but culture negative. This  culture negativity inspite of a positive KOH 
mount ,could  be due to  the non-viable fungal elements , inadequacy in sampling  and 
non-reported  treatment with antifungal agents[110] .As the median time to culture 
positivity is about 2 weeks ,the efficiency of direct microscopic examination plays an 
important role in rapid  diagnosis and treatment. 
 
 In our  study,   Candida species   was  the   most  common   isolate  (39.50%), 
followed  by  non-dermatophytic  moulds  (34.58%)  and dermatophytes (25.92%) 
[TABLE.13]. This is  similar to the study conducted  by Dogra S et al in India[14] and 
by Glucan et al[105]. 
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 Conversly Al-Mutairi et al [98] in his study on Clinicomycological profile on 
onychomycosis among diabetic patients reported  the  predominant pathogen as 
dermatophytes[98].     
 
 The most common  Candida species isolated was Candida parapsilosis (62.5%) 
followed by Candida albicans (25%) and Candida tropicalis(12.5%) [TABLE.14]. 
This is smilar to the study by Gahannaoum et al[42], who reported the most common 
species of Candida to be C.parapsilosis (66.6%) followed by C.albicans (16.7%), 
C.guilliermondii (11.9%), C.tropicalis (2.4%) and  C.lusitaniae(2.4%).This is in 
contrast to a study by  Al-Mutairi et al who observed Candida albicans as the most 
common species [98]. 
 
 The  epidemiological  pattern of onychomycosis caused by Candida species was 
analysed. It was found that farmers and housewives were most commonly affected. 
There was a history of trauma in 12.5% of patients[TABLE.15]. Finger nails were the 
most common site of infection.      A study by Rakshit et al[117]  in North India about 
Candida as an emerging pathogen in onychomycosis,also reported that Candida species   
are associated with finger nail infection among female patients.  
 
 Interpretation  of  isolation  of  non-dermatophytic  moulds  from 
onychomycosis  requires  caution because  of their  presence in environment as 
contaminants. In the present  study ,diagnosis  was  based on English and Walshe 
criteria. [57][58]. Nondermatophytic moulds were isolated in 34.58%  of the study 
population. This is similar to the study by Leelavathi et al [100] who also reported a 
similar isolation rate of nondermatophytic moulds. 
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 In the present study,among non-dermatophytic moulds(NDM), Fusarium 
species was the most common etiological agent (57.14% ), followed by Aspergillus 
fumigates (14.27%), A.niger (10.71%), Bipolaris species (7.14%) and Absidia 
(Lichtheimia)  species, Penicillium  species  and Syncephalastrum species (3.58% ) 
each repectively [TABLE.16].  
 
 Fusarium  species and Aspergillus niger were isolated by Al-Mutairi et al [98] in 
75% and 25% of NDM respectively . There are few reports of isolation of the other 
agents such as Bipolaris species, Absidia species, Penicillium species and 
Syncephalastrum species among diabetic patients with onychomycosis. But these 
species were reported in non diabetic patients with onychomycosis by  Purnima Barua 
et al [101] and  Veer et al[102]. 
 
 The nondermatophytes were isolated in 34.58% of patients  whereas 
dermatophytes were isolated in 25.92% of infection. This may be due to the ubiquity of 
varied species of fungi  in  environment as well as  the active nature of our lifestyles 
which increases the vulnerability to trauma. According to Tosti et al [104] , the hot and 
humid subtropical and tropical climates  could  be the probable cause of increased 
frequency of nondermatophytic mould infection.  
        
 The epidemiological pattern of onychomycosis caused by nondermatophytic 
moulds was analysed. It was observed that  nondermatophytic onychomycosis was 
predominantly seen in males,elderly and in farmers.Other comorbid conditions was 
present in 46.43% of patients[TABLE.17]. This is consistent with the study by Hwang 
SM et al[107]. Among the 16 isolates of Fusarium species,two of the isolates in our 
study was isolated in post renal transplant recipients with diabetes mellitus.Lamb et al 
in his study isolated Fusarium species in chronic renal failure patients undergoing 
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hemodialysis.In his study on frequency of onychomycosis in chronic renal failure 
patients,he stated that diabetics are 88% more likely to develop onychomycosis than 
non-diabetics[25]. The nondermatophytic moulds depend on the unkeratinized 
intercellular cement  otherwise it will take the advantage of  partial denaturing of nail 
keratin by pre-existing disease or trauma[86 ]. 
 
 In our study,among the dermatophytes the most common  isolate was 
Trichophyton rubrum (61.90%),followed byTrichophyton tonsurans (28.58%), 
Epidermophyton floccosum (4.76%) and Microsporum gypseum (4.76% ) [TABLE.18]. 
T.rubrum  was the most common etiological agent among dermatophytes which 
correlates well with other studies[12][98] which have reported higher occurrence of 
T.rubrum infection among diabetic patients with onychomycosis. Al-Mutairi et al 
observed  a similar occurrence of dermatophytic infection  contributed by pathogens 
such as T.rubrum(72%), T.tonsurans(5.5%), M.gypseum(5.5%) and  T.mentagrophytes 
(16%)[98]. 
 
 Conversely, Romana C et al[122] reported the predominant pathogen as 
T.mentagrophytes  in  his study on prevalance of dermatophytic skin and nail infection 
among diabetics.      
 
 Extraungual  site  involvement was present in 52.38% of dermatophytic nail 
infections.Tinea corporis  was  found to be associated with 38.46% of T.rubrum  
infection. Tinea pedis was found to be associated with 33.33% of T.tonsurans. 
Epidermophyton floccosum was found to be associated with both  tinea corporis and 
tinea cruris.[TABLE.19]. Szepietowski et al [36] observed the  coexistense  of  toe nail 
onychomycosis  with  tinea  pedis (33.8%) , tinea cruris (4.2%), tinea 
corporis(2.1%),tinea capitis(0.5%),tinae manuum (1.6%) and hypothesized that  
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infected toenails may be a site from which the mycotic infections can spread to other 
body areas.Therefore,in diabetic patients  effective therapy for onychomycosis is  
essential not only to treat the affected toenails but also to prevent spreading the 
infection to other sites .                  
 
 The choice of antifungal agent is different in yeasts,filamentous moulds and 
dermatophytes. The drug of choice of  OM in diabetic patients is  same as that of the 
patients without diabetes. But elderly diabetic patients require  a longer duration  to 
treat  and there may be associated complications like  cellulitis, diabetic foot ulcers  and  
gangrene, which will  increase the  admission rates in hospital and surgical 
interventions[89]. Onychomycosis   may also serve as a  reservoir of infection. Reports 
of drug-resistant Candida species in onychomycosis have not appeared, although 
antifungal resistance to fluconazole has been documented in oral candidiasis in 
immunocompromised patients[35]. By doing in-vitro antifungal susceptibility  an 
effective antifungal agent can be selected for treatment and thus helps in optimizing the 
therapy[69].  
 
 All the three species of Candida namely C.parapsilosis,C.albicans and 
C.tropicalis were sensitive to fluconazole and voriconazole by disk diffusion 
method[TABLE.20].   The MIC of  these  isolates to itraconazole and voriconazole 
were   in the  range of  0.0625-0.125  μg/ml   and  0.0313μg/ml 
respectively[TABLE.21].All of the isolated Candida species were sensitive to 
itraconazole and voriconazole and   found  to have lower MIC ranges [108].This was in 
consistent with a study by  Bueno et al [119] who observed  that itraconazole and 
voriconazole  were the most active agents. 
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 The MIC   range  of  the three  Candida species  for  ketoconazole was  0.5-1 
μg/ml . A study  by Ozcelik  et al [109]showed that all Candida isolates were in the MIC 
range of about 0.03-32  μg/ml for ketoconazole .Some of the C.albicans(n=14) isolates 
showed intermediate susceptibility (16-32μg/ml) in his study.  
 
 The MIC range of  Candida parapsilosis,Candida albicans and C.tropicalis for  
fluconazole were 1- 2 μg/ml.All of the isolates were found to be  sensitive.  A study by 
Espinel Ingroff  reported the MIC range of Candida  parapsilosis,Candida albicans and 
C.tropicalis for  fluconazole as 0.25- 8,0.12 – 64 and 0.25 – 64 μg/ml respectively[115].         
 
 All of  the Candida species were sensitive to voriconazole and fluconazole  in 
both disk diffusion and microbroth dilution method. Results of disk diffusion correlated 
well with the MIC by microbroth dilution method. Therefore, disk diffusion test can be 
used as an cost effective alternative to microbroth dilution technique. This has also 
been suggested  by a study by  Deepak kumar et al [111]. 
 
 The MIC range  of  Fusarium species  for voriconazole in our study was 4- 8 
μg/ml[TABLE.22]. This is similar to a study by Espinel Ingroff[115] who reported a 
MIC range of 4 to 16 μg/ml. Other studies have reported a lower MIC range of 0.5 to 4 
μg/ml [112,116] .   
 
 The MIC range of Fusarium species for itraconazole in our study was  8-16 
μg/ml. A study by Espinel Ingroff  [115] for   Fusarium species, the MIC range of 
itraconazole was reported to be 1-16 μg/ml. 
 
 The MIC range of Fusarium species for ketoconazole in our study was 16 - 32 
μg/ml which is similar to the MIC range of  Pujol et al[113] (1.60–51.20 μg/ml) and by 
Sekhon  AS et al[114] who reported the range as 3.125-100 μg/ml. 
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 The MIC range of Fusarium species for fluconazole in our study was 32- 64 
μg/ml which is similar to that of the study by Bueno et al[119] who reported a MIC range 
of 4-64 μg/ml. 
 
 In our study,  the MIC values for all  of the evaluated  drugs with Fusarium 
species were found to be  higher  than those obtained against the other NDM, which is 
in agreement with the poor therapeutic response to fungal infections caused by 
Fusarium species  as reported in some studies[119,120,121]. 
 
 The MIC range of Aspergillus species in our study for voriconazole was 0.0313 
μg/ml  which  correlates with study  by Espinel Ingroff (0.0625-1 μg/ml )[115] .  The 
MIC range of itraconazole in our study was 0.5-1 μg/ml . A higher MIC range of 
itraconazole was observed by Espinel Ingroff (0.12 – 16 μg/ml) for Aspergillus species. 
 
 The MIC range of Bipolaris species for voriconazole and itraconazole were  
0.0625μg/ml and   1 μg/ml   respectively which was similar to the observation of  
Espinel Ingroff  (Vori-0.12–1.0 μg/ml and Itra-0.03-0.12 μg/ml) [115].  
 
 The MIC  range of voriconazole was found to be lower when compared to other 
azole drugs  for all non-dermatophytic moulds and can be used as an alternative drug in 
immunosuppressed patients.  
 
 The MIC  range of dermatophytes in our study was, for Fluconazole:4-32 
μg/ml, Ketoconazole : 0.5 – 2 μg/ml, Itraconazole : 0.25-1 μg/ml and Terbinafine: 
0.0313μg/ml [TABLE.23] .Terbinafine was found to have the lower MIC ranges among 
the evaluated drugs. 
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 Our study correlates with the study by Pankajalakshmi[118] who observed the 
MIC range of Ketoconazole,Itraconazole and Terbinafine as 0.1 – 10μg/ml ,0.01-
1μg/ml and 0.001-0.01 μg/ml  respectively. A study by M.A.Ghannoum et al [72]  
reported the MIC range of Fluconazole,Ketoconazole,Itraconazole and terbinafine  as  
0.12-16 μg/ml ,    0.12-64 μg/ml, 0.001-0.05 μg/ml and  0.001-0.5 μg/ml respectively.In 
his study  the MIC of  ketoconazole was found to be higher. This variability may be  
due to important methodological differences among  laboratories like incubation 
temperature.[70 ] 
 
 However,  for  onychomycosis,MIC breakpoints for diabetes mellitus patients  
have not yet been established,it remains unclear whether the in vitro activity of  
antifungal drugs is predictive of the clinical outcome[119].   
 
  
  
 
 
 
 
 
 
        SUMMARY 
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SUMMARY 
 
 About  175  clinically diagnosed  cases  of onychomycosis in diabetic patients 
attending the  outpatient clinic of Dermatology  and Diabetology departments, Madras  
Medical college & RGGGH for a period of one year were included in the study. Nail 
scrapings and sub ungual debris were collected from the patients and  subjected to 
direct examination and culture.  
 
 Majority of the patients were in the age group between 51-60 years(35.43% ).  
 The male  to  female  ratio  was 1.08 : 1.  
 Farmers were most commonly involved (44%) followed by housewives 
(26.28%). 
 Majority of the study population had Type II diabetes mellitus (92%) .   
 Most of the patient had  nail  affiliction(52.57% ) for a duration of 1 to 5 years. 
 Toe nail onychomycosis was found in 68% of patients followed by both  nail 
involvement(17%) and  finger nails  in 15% of  patients. 
 The most common clinical presentation was DLSO(89.14% ) . 
 The commonest degree of nail involvement was  mild type of 
onychomycosis.(87%) . 
 There was no statistical significance between severity of onychomycosis and 
type of diabetes mellitus,  blood sugar levels and duration of diabetes mellitus . 
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 The  culture   positivity rate  was 46.28% and potassium hydroxide mount  was 
positive in 70.29% of patients. 
 Candida  species was the most common etiological agent(39.50%) followed by     
non-dermatophytic moulds (34.58% )and  dermatophytes(25.92%). 
 Among the Candida species ,C.parapsilosis was the most common etiological 
agent(62.5%).C.albicans (25%) and C.tropicalis (12.5%) were the other 
pathogens. 
 Among the patients with  Candidial Onychomycosis , female patients(65.62%) 
,farmers (37.5%)and housewives(31.25%) were  involved commonly. Finger 
nails(43.75%) were found to be involved  most commonly. 
 Among non-dermatophytic moulds,Fusarium species was the most common 
etiological agent (57.14%)  followed by  A. fumigatus  (14.27%), A.niger 
(10.71%),Bipolaris species(7.14%), Absidia species (3.58%), Penicillium 
species ( 3.58%) and   Syncephalastrum species  ( 3.58%)  . 
 Among  non-dermatophytic  onychomycosis, elderly  males(60.72%), farmers 
(50%) and patients with a H/O.trauma (21.43%) were  involved predominantly. 
Toe nails(75%) were  found to be involved commonly. 
 Among the dermatophytes, T.rubrum was the predominant  agent  isolated 
(61.90%) followed by T.tonsurans (28.58% ) and  E.floccosum( 4.76%)   , 
M.gypseum ( 4.76%) . 
 Extaungual  site involvement was present in 52.38% of dermatophytic nail 
infection. 
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 Tinea corporis  was  found to be associated with 38.46% of  T.rubrum  
infection. Tinea pedis was found to be  associated with 33.33% of T.tonsurans. 
Epidermophyton floccosum was found to be associated with both  tinea corporis 
and tinea cruris. 
 Antifungal susceptibility testing was done by disk diffusion method and 
microbroth dilution  method for  Candida species. 
 All  the Candida species  were sensitive to azole drugs . 
 There was a good correlation between disk diffusion  test and microbroth 
dilution method for  Candida species. 
 For  nondermatophytic moulds  except  Fusarium spp ,voriconazole was  found 
to have a lower MIC range  than  other azole  drugs . 
 Fusarium species had a higher MIC range for azole drugs.  
 Terbinafine was  found to have  lower MIC range in case of dermatophytes. 
 Itraconazole was found to have a lower MIC range among  the evaluated azole 
drugs in dermatophytes. 
                                  
  
  
 
 
 
 
 
 
CONCLUSION 
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CONCLUSION 
 
 A clinical suspicion of onychomycosis  is  crucial  in  patients  with  diabetes 
mellitus.Type II diabetes mellitus patients were involved most commonly and the most 
common clinical presentation among them was distal lateral subungual 
onychomycosis.Majority of the patients had mild onychomycosis.A siginificant group 
of  patients  had  extraungual  site involvement. 
 
 Our study revelaed that there was no correlation between severity of 
onychomycosis and type of diabetes mellitus,duration of diabetes and blood sugar 
levels. 
 
 A combination of direct examination and culture would yield the  best results 
for  identification   of  the exact pathogen and for confirmation of diagnosis.  
 
 This study highlights the role of Candida parapsilosis  as a primary pathogen in 
diabetic patients with onychomycosis. Fluconazole still remains as an effective 
antifungal agent among the Candida species. 
 
 Non dermatophytic moulds ,which are  generally considered  as  contaminants , 
are now emerging as primary pathogens,  though their definitive diagnosis should be 
done with caution.Repeated isolation on consecutive sampling will help to ensure the 
clinical significance of the isolates.Fusarium  species  which can cause  disseminated  
infections in immunocompromised patients were the predominant nondermatophytic  
pathogens. 
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 Dermatophytes were less commonly isolated than Candida species and 
nondermatophytic moulds,T.rubrum  being  the most common isolate. Terbinafine was 
found to have a lower MIC range against dermatophytes. 
 
 The  in vitro antifungal susceptibility patterns  showed a comparable results 
with  previous    studies.However,for onychomycosis,  clinical breakpoints have not yet 
been estabilished .Therefore it remains unclear whether  the  in vitro activity of 
antifungal drugs is predictive of  clinical outcome. Hence, routine antifungal 
susceptibility testing along with the clinical outcome  should be performed  in future  
studies. 
 
           In addition, the diabetic   patients should be educated regarding  the  importance  
of  foot and nail care  and  early treatment  should be considered  as  an essential 
component  in  the management of these patients.  
  
 
 
 
 
 
 
APPENDICES 
 
 APPENDIX - 1 
LIST OF ABBREVIATIONS USED 
ATCC  -  American type culture collection 
CO  -  Candidial onychomycosis 
CLSI            -  Clinical Laboratory Standard Institute 
DM        -  Diabetes Mellitus 
DMSO  - Dimethyl Sulfoxide 
DLSO  -  Distal and lateral  subungual onychomycosis 
TM      -           Dermatophyte Test Medium 
EO  -          Endonyx Onychomycosis 
HIV        -           Human Immunodeficiency Virus 
HPE             - Histopathological Examination 
KOH  -          Potassium hydroxide 
LPC  -          Lactophenol Cotton Blue mount 
MO  - Mixed Onychomycosis 
MIC  - Minimum Inhibitory Concenteration 
NDM        - Non Dermatophytic Moulds 
NDO        - Nondermatophytic Onychomycosis 
OM  -   Onychomycosis  
PAS  - Periodic Acid Schiff 
PDA                -          Potato Dextrose Agar 
PCR                -          Polymerase Chain Reaction 
PSO                -          Proximal subungual onychomycosis 
RPMI              -          RoseWell Park Memorial Institute 
SDA                -          Sabourauds Dextrose Agar 
SO                   -          Secondary Onychomycosis 
SWO               -          Superficial White Onychomycosis 
TDO                -         Total Dystrophic Onychomycosis 
YNB                -         Yeast Nitrogen Base 
                                            
  
 APPENDIX – 2 
MEDIA ,STAINS AND REAGENT 
Sabouraud  Dextrose  Agar  with  Antibiotics  
Composition of Sabouraud  Dextrose Agar  
       Dextrose : 20 gm   
       Peptone : 10 gm  
       Agar : 20 gm  
       Distilled Water : 1000 ml  
       Final pH : 6.9  
            The ingredients are dissolved by boiling. Chloramphenicol(50mg/lit) and 
Cycloheximide(500mg/lit) was added . Chloramphenicol was dissolved in 10 ml of 
95% ethanol and added to boiling medium. Cycloheximide was dissolved in 10 ml of 
acetone and added to the boiling medium. Autoclave at 121°C for 15 minutes, 
Dispense in sterile tubes and allow to cool in slanted position.  
DERMATOPHYTE TEST MEDIUM: 
Papaic digest of   Soyabean  : 10gm 
Glucose                                :10gm 
Phenolred                             :0.20gm 
Agar                                     : 20gm  
Actidione                             :500mg 
Gentamicin                          :100mg 
Final pH: 5.5         20.1gm of  powder  is dissolved in 500ml of distilled water. Heat to 
boiling to dissolve the medium completely.Autoclaved  at 121°C for 15 mins and 
dispensed in test tubes. 
 
 POTATO  DEXTROSE  AGAR  
Potato Infusion : 200 g         
Dextrose : 20 g  
Agar : 15 g          
Distilled Water : 1 Lit          
Final pH: 5.6 
        39  grams of media is suspended in 1000 ml of distilled water.Heat to boiling to 
dissolve the medium completely. Autoclave at 1210 C for  15 minutes. Cool to 500 C & 
pour into  sterile test tubes/petridish. 
CORN  MEAL  AGAR  MEDIUM: 
 Cornmeal    : 8gm 
Agar              : 4gm 
Tween 80(1%): 2ml 
Distilled water : 200ml 
                    Heat cornmeal and water at 60ºC for 1 hour and filter through filter 
paper.Add distilled water to make it 200ml and then add agar.Tween 80 is then 
added.Autoclave it at 121 ºC for 15 mins. 
YEAST NITROGEN BASE MEDIUM 
Part A : Agar 40gms/lit 
Part B : Yeast nitrogen base 6.7gms/lit 
            40 grams of part A  media is suspended in 900 ml of distilled water. Heat to 
boiling to dissolve the medium completely.Autoclave at 121º C for 12 minutes.Cool to 
50° C and mixed with sterile part B solution aseptically. 
 
 
 CHROMAGAR CANDIDA MEDIUM: 
Ingredients                                              Gms/L 
Peptone                                                     15.00 
Yeast extract                                              4.00 
Dipotassium hydrogen phosphate             1.00 
Chromogenic mixture                               7.22 
Chloramphenicol                                      0.50 
Agar                                                         15.00 
 Final pH: 6.3. 
       42.72 grams of media is suspended in 1000 ml of distilled water.Heat to boiling to 
dissolve  the  medium  completely. Donot  autoclave. Cool to 50° C and pour in sterile 
petridish. 
MUELLER HINTON AGAR : 
Ingredients                                              Gms / Litre 
Beef extract                                                   3.000 
Casein acid hydrolysate                                17.500 
Starch                                                            1.500  
Agar                                                             17.000 
Final pH (at 25°C)  7.3±0.2 
           38grams of media is suspended in 1000 ml of distilled water.  Add 20gm of 
glucose(2%) and  methylene blue (0.5µg/ml) is added. Dissolve  the  medium 
completely. Dispense and sterilize by autoclaving at 115-121°C for 10 minutes. DO 
NOT OVERHEAT. 
  
 CHRISTENSEN’S UREASE TEST MEDIUM: 
Peptone                                           :1g 
Sodium chloride                              :5g 
Dipotassium hydrogen phosphate   :2g 
Phenol red                                       :6ml 
Agar                                                : 20g 
Distilled water                                :1 ltr 
10% sterile solution of glucose l0ml 
Sterile 20% urea solution l00ml 
                     Sterilize the glucose and urea solutions by filtration. Prepare the basal 
medium without glucose and urea, adjust to pH 6.8-6.9 and sterilize by autoclaving in 
a flask at 121°C for 30min. Cool to about 50°C, add the glucose & urea, and the tube 
is placed as slopes. 
 
SUGAR FERMENTATION TEST MEDIUM: 
To the basal medium of peptone water, add sterilised sugars of  2%. 
Indicator : Bromothymol blue with Durham’s tube. 
Basal medium peptone water 
Sugar solutions: 
             Sugar 2ml 
             Dislilled water l00ml. 
 
            RPMI 1640 MEDIUM[With glutamine and without bicarbonate] 
     Obtained commercialy as a dehydrated powder.Suspend 8.4gms of media in 900ml 
of sterile distilled water.Stir it  to completely dissolve the medium donot heat.Sterilize 
the medium by filtration.Final pH=7.0. 
 GRAM STAINING 
Methyl violet (2%)              : l0g Methyl violet in l00ml absolute alcohol in 1litre of 
                                              distilled water (primary stain) 
Grams Iodine                      :  l0g Iodine in 20g KI 
                                               (fixative) 
Acetone                              : Decolourising agent 
Carbol fuchsin                    : 1% Secondary stain 
 
POTASSIUM  HYDROXIDE  MOUNTS  
It is prepared from the following ingredients  
Potassium hydroxide : 20 gms  
Glycerol : 10 ml  
Distilled water : 80 ml  
         To a solution of 20% KOH, 10% Glycerol is added to prevent drying.Mix 
ingredients and store at room temperature. For 40% KOH 40gms of  potassium 
hydroxide is added. 
 
LACTOPHENOL COTTON BLUE STAIN  
The lacto phenol cotton blue (LPCB) is used to study the morphological features of 
the fungal isolates.   
It contains the following ingredients:  
          Melted phenol : 20 ml  
          Lactic acid : 20 ml  
         Glycerol : 40 ml  
         Cotton blue : 0.05 gm  
         Distilled water : 20 ml  
  Mix all the reagents properly and dissolve 0.05 g of cotton blue stain in the 
distilled water before mixing with the remaining reagents. The phenol acts as 
disinfectant, lactic acid preserves the morphology of the fungi and glycerol is 
hygroscopic agent which prevents drying. The cotton blue stains the outer wall of the 
fungus. Tease out of a fragment of the culture on a glass slide in a drop of LCB using 
two teasing needles. Put of a coverslip and examine under the microscope. If the plane 
LCB is used the edges of the coverslip can be sealed with nail polish to keep it for 
longer period of time.  
  
  
 
 
 
 
 
            
          ANNEXURES 
 ANNEXURE – 1 
 
 ANNEXURE – 2 
 
PROFORMA 
 
Name :                                                                       OP NO: 
Age:                                                                           Ward: 
Sex: 
Occupation: 
Address: 
Presenting complaints 
Personal history 
Past history 
Prior antifungal therapy 
 
Microbiological  investigation: 
Direct examination  - KOH: 
Culture : Fungal culture 
Speciation  
For Candida species 
             CHROM agar medium 
             Cornmeal agar medium 
             Urease test 
             Germ tube test 
             Assimilation and Fermentation of sugars 
 
      For Trichophyton species 
              Urease test 
              Lactophenol cotton blue mount 
              The Microslide culture 
 
      Antifungal sensitivity pattern:- 
 
 
 
 ANNEXURE - 3 
INFORMED CONSENT FORM 
 
STUDY TITLE : “A study on Mycological profile of Onychomycosis in 
Diabetic patients  in a Tertiary care Hospital and their antifungal susceptibility 
pattern” 
 
 I…………………………………………, hereby give consent to participate in 
the study conducted  by Dr.A. Gomathi Chitra, Post graduate at Institute of 
Microbiology, Madras Medical College, Chennai and to use my personal clinical data 
and the result of investigations for the purpose of analysis and to study the nature of the 
disease, I also give consent to give my clinical Specimen (nail scrapings/subungual 
debris) for further investigations. I also learn that there is no additional risk in this 
study. I also give my consent for my investigator to publish the data in any forum or 
journal. 
 
   
Signature/ Thumb impression                                     Place                                    
                Of the patient/ relative                                             Date 
 
 
Patient Name & Address: 
 
Signature of the investigator: 
 
 Signature of  guide: 
  
 MASTER CHART 
 
  
 
 
  
  
  
  
 MASTER CHART – KEY 
 
M  - Male  
F   - Female 
FN   - Finger nail  
TN   -  Toe nail 
NG   - No growth 
KOH  - Potassium hydroxide 
P  - Positive 
N   - Negative 
DLSO  - Distal Lateral Subungual Onychomycosis  
PSO   - Proximal Lateral Subungual Onychomycosis  
TDO   -  Total dystrophic Onychomycosis  
MIC   - Minimum inhibitory concentration  
DM   - Diabetes mellitus 
HT   - Hypertension 
CKD   - Chronic Kidney Disease 
FLU  - Fluconazole 
ITRA   - Itraconazole 
KET  - Ketoconazole 
VORI  - Voriconazole 
TERBI - Terbinafine 
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